ORF_ID	Contig	Start	Stop	Orientation	Cut_Off	Pass_Bitscore	Best_Hit_Bitscore	Best_Hit_ARO	Best_Identities	ARO	Model_type	SNPs_in_Best_Hit_ARO	Other_SNPs	Drug Class	Resistance Mechanism	AMR Gene Family	Predicted_DNA	Predicted_Protein	CARD_Protein_Sequence	Percentage Length of Reference Sequence	ID	Model_ID	Nudged	Note
BGC0000723.1|Validamycin_1 # 48 # 1076 # 1 # ID=1_1;partial=00;start_type=GTG;rbs_motif=AAGG;rbs_spacer=5bp;gc_cont=0.667	BGC0000723.1|Validamycin_1 	48	1076	+	Loose	500	28.4906	mphO	33.72	3004543	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	GTGCTGCCGCACCGCAGCTTCTTCAACGTGGCCGAGGCCATGGAGCAGCACGGTCTCGACTGGTTCGACTGGCTGCCGGGCGACCGCAGTCTGATCGGCCTGCCGGGCTTTCACATAGGCGGCTTCTCCTACGCGATGCAGGGCTTCAACGCCGGGGTGACGATCGTCTCCATGCCCATGTTCGTCAGCTCGTCAGCTCTCAGGCTCATCAGAGAACTGCGGATCACCACCGCGATCGTGGCGCCCGCCATGCTGCAACTGCTCTTCAACGAGCCGGATGCCAACCCAGAGTGCTTCCAGTCGTTGCGCAAAGTCGTCTACGGTGGCTCCCCCATCTCGGCGCCGCTGCTTGAGCAGTGCATGAAGATGATCGACTGCGACTTCCTGCAGATCTACGGGAGCAGCGAGACAGGTAACTTCGCGGCTTGTCTGCCACCCGAGGACCACAGGCAGGGCAACCCCCGGCTGCTGGCCGCCGGCCGGGCGTACCCGGGCATCACGCTGCGGATCATCGACCGGGACGGCAAACCGGTGCCACCTGGCACGGTCGGAGAGGTCTGCGTCCGCTCGCCCGCCCGGATGCTGGAGTACTGGCGTCGCCCCGACGCCACGGCCGAGACCCTGGTCGACGGATGGATCCGCATGGGCGACGCGGGCTACCTCGACGAGGACGGCTACCTGTTCGTCAGCGACCGCGTCAACGACATGATCATCGTGGCGGGAGAAAACGTATATCCCGCCGAGATCGAGGCCGCGCTGTGCGCCCACCCAGCGGTCCTCGAAGTCGCGGTCGTGGGCATTCCGCACCCCAGGTGGGGTGAATCGGTGCACGCCCGCGTGGTCCTTGAGCCGGGCCAGCGCGTCACCCCCCGCGAGCTGATGCTTTCTCTGCGCGGCCGCATCGCGGACTTCAAGGTGCCCACCAGTTACGACTTCGCCACGGCCCTGCCGAGAAATCCGAGCGGCAAGGTCCTGCGCAGGATGGTGCGTGGCGAACTCGCGGAGAAGTCGCCGCGGGTCGGCCGCTGA	MLPHRSFFNVAEAMEQHGLDWFDWLPGDRSLIGLPGFHIGGFSYAMQGFNAGVTIVSMPMFVSSSALRLIRELRITTAIVAPAMLQLLFNEPDANPECFQSLRKVVYGGSPISAPLLEQCMKMIDCDFLQIYGSSETGNFAACLPPEDHRQGNPRLLAAGRAYPGITLRIIDRDGKPVPPGTVGEVCVRSPARMLEYWRRPDATAETLVDGWIRMGDAGYLDEDGYLFVSDRVNDMIIVAGENVYPAEIEAALCAHPAVLEVAVVGIPHPRWGESVHARVVLEPGQRVTPRELMLSLRGRIADFKVPTSYDFATALPRNPSGKVLRRMVRGELAEKSPRVGR	MTETSPSSPSSATADAGTPPPADLEQLLALAADHGLDLLGDSLRTEEIGLDFRVAFARSRDWQDWVLRIPRRAEVLARAAVEGRLLAHLAPHLDIAIPDWRISTERLIAYPLLPGTPGLTVSADGTVEWHVDMASTEYARALGTFLAQLHTVDPEEAAATGIPSRTPSEVRGVWREDLTRVAEAFPIAPALRERWEAWLAEDSYWPDRSVLTHGEVYPGHTLVEGERLSAVLDWTTASVGDPARDLMFHRSSAPPEAFAATLAAYVAGGGTLHPRLGEHAEEMFSASPLAYGLYALETGEEEHRAAAAAALDPPDAD	107.89	gnl|BL_ORD_ID|2754|hsp_num:0	3219		
BGC0000723.1|Validamycin_3 # 2169 # 2942 # -1 # ID=1_3;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.760	BGC0000723.1|Validamycin_3 	2169	2942	-	Loose	1000	28.4906	MCR-6.1	42.42	3004501	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	MCR phosphoethanolamine transferase	GTGACGCGGCCCGCGACGGCGGCCCGCCGCCCCACGGCCCGCACGGGAGCGGTCCTCCTCACGGCGGCCACGGCCGCGGCCTGGACGTGGACGGCACTGCGCCGGGGCGACATGGGAGCGGGGACCGCGGCCGGCGAGCTGCCCGCCTTCCTGGGCGCGTGGACGATCATGATGGCCGCGATGATGCTGCCGGCCACGGCACCGGTGGCCTCGCTGTACGCGCGGACCGCACCCGCGCACCGGACGCCGCGCCTGATCGCGTTCACCGCCGGCTACCTGCTGGTCTGGGCAGCCGCCGGGCTGCCGGCGTACGCCCTGGCCGCCGGGGCGGCACGGGTGGCGACCGCCCATCCCACCGCGGGGACGGCGGTGGCCGCCGCCGTCTTCGCCCTCAGCGGTGCCTACCAGCTCACCCCCCTCAAGGACGTCTGCCTCACCCGGTGCCGCTCACCGGTCGGTTCGCTGCTGCACTACGCGTCGTACCGCGGCCCCGCCCGCCACCTGCGGGCCGGGGCCCATCACGGAGCGTTCTGCCTGGGCTGCTGCTGGTCCTTGATGCTGCTGCTCACCGCGTTCGGGGTGATGAACCTCTGGGCCACGGTGGGCCTGGCCGCCGTCATCACCGCCGAGAAACGCCTGCCACGGGGCCGTCTCCTCGCCCGCGCCGTGGGACTCGCCTCGCTCGCCCTCGCGATCGGCGTCTTCTGGCTGCCCCTGCTGGCGCCGAACCTCACGGGCGGCGGCATGACGGACATGGGCCTGCGAGGACCGTGA	MTRPATAARRPTARTGAVLLTAATAAAWTWTALRRGDMGAGTAAGELPAFLGAWTIMMAAMMLPATAPVASLYARTAPAHRTPRLIAFTAGYLLVWAAAGLPAYALAAGAARVATAHPTAGTAVAAAVFALSGAYQLTPLKDVCLTRCRSPVGSLLHYASYRGPARHLRAGAHHGAFCLGCCWSLMLLLTAFGVMNLWATVGLAAVITAEKRLPRGRLLARAVGLASLALAIGVFWLPLLAPNLTGGGMTDMGLRGP	MTQHSPWYRRPVNPYLLMSVVALFLSATANLTFFDKITNTYPMAQNAGFVISTALVLFGAMLLITVLLSYRYVLKPVLILLLIMGAVTSYFTDTYGTVYDTTMLQNALQTDQAESKDLMNMAFFVRIIGLGVLPSILVAWVKVDYPTLGKSLIQRAMTWGVAVVMALVPILAFSSHYASFFREHKPLRSYVNPVMPIYSVGKLASIEYKKATAPKDTIYHAKDAVQTTTPAERKPRLVVFVVGETARADHVQFNGYSRETFPQLAKIDNLANFSQVTSCGTSTAYSVPCMFSYLGQDDYDVDTAKYQENVLDTLDRLGVGILWRDNNSDSKGVMDKLPASQYFDYKSATNNTICNTNPYNECRDVGMLVGLDDYVSTNQGKDMLIMLHQMGNHGPAYFKRYDEQFAKYTPVCEGNELAKCEHQSLINAYDNALLATDDFIAKSIDWLKTHQANYDVAMLYVSDHGESLGENGVYLHGMPNAFAPKEQRAVPAFFWSNNPSFTPTASDTVLTHDAITPTLLKLFDVTADKVKDRTAFIR	47.77	gnl|BL_ORD_ID|2726|hsp_num:0	3129		
BGC0000723.1|Validamycin_4 # 2939 # 3553 # -1 # ID=1_4;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=13bp;gc_cont=0.704	BGC0000723.1|Validamycin_4 	2939	3553	-	Loose	1900	23.8682	TriC	60.0	3003681	protein homolog model	n/a	n/a	triclosan	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCATGGAACGTGACCGGTACCTACTTCGAAAGCTGCAACTGCGACACCGTCTGCCCCTGCACCACCTCGGGCCTGACCGCCCCTGCCGACAACGAGCGCTGTCAGGTGACGTTCGCGTTCCACGTCGCACAGGGTGAGGTCGACGGCGTGGACGTGTCCGACCGCAACGTGGTCGTCTTCGCCGACGCGCCGCGCGTGATGGCCGACGGCGGCTGGCAGGTGGCGCTGTACGTCGACGCCTCGGCCGACGACGGCCAGGCGGAGGCGCTGGGCAAGGTCTTCTCCGGGCAGGCGGGCGGGCCGATGGCGGCGCTCGTGCCCCTCGTCGCCGAGGTGCTCGGCGTCGAACGCGCACCCATCGACTTCCACGACGACGGCCGCCGGCACACCGTGCGGGTGGCGGACGCCATCCACATCGAGATCGAGGACCAGGTCGCCCCGCAGTTCGGCGACGACGGTCCCGTGATGAAACTGTCCGGCATGTTCCACCCGGCGAACAGCACGCTGACCGTCGCCAGGTCGACACGGGCCGTCGGCCACGGCGTGCACGGCCGCTCCTGGGACTTCACCGGCCACAACGCCCACTCGGCGCCCTTCTCGTGGTCGGCGTGA	MAWNVTGTYFESCNCDTVCPCTTSGLTAPADNERCQVTFAFHVAQGEVDGVDVSDRNVVVFADAPRVMADGGWQVALYVDASADDGQAEALGKVFSGQAGGPMAALVPLVAEVLGVERAPIDFHDDGRRHTVRVADAIHIEIEDQVAPQFGDDGPVMKLSGMFHPANSTLTVARSTRAVGHGVHGRSWDFTGHNAHSAPFSWSA	MKGGFNLSDWALRHQSLVWYLMAVSLVMGVFSYLNLGREEDPSFAIKTMVIQTRWPGATVDDTLEQVTDRIEKKLEELDSLDYVKSYTRPGESTVFVYLKDTTKAGDIPDIWYQVRKKISDIQGEFPQGIQGPGFNDEFGDVFGSVYAFTADGLDFRQLRDYVEKVRLDIRSVKDLGKVQMIGAQNEVIYLNFSTRKLAALGLDQRQVVQSLQAQNAVTPSGVVEAGPERISVRTSGNFRSEKDLQAVNLRVNDRFYRLSDLASISRDFVDPPTSLFRYKGEPAIGLAVAMKEGGNILEFGEALNARMQEITGELPVGVGVHQVSNQAQVVKKAVGGFTRALFEAVVIVLIVSFVSLGLRAGLVVACSIPLVLAMVFVFMEYTDITMQRVSLGALIIALGLLVDDAMITVEMMITRLELGDSLHDSATYAYTSTAFPMLTGTLVTVAGFVPIGLNASSAGEYTFTLFAVIAVALLLSWIVAVLFAPVIAVHILPKTLKHKSEQKKGRIAERFDSLLHLAMRRRWTTIFLTALLFGVSLFLMKFVQHQFFPSSDRPELLVDLNLPQNSSIHETRAVMDRLEATLKDDEDIDHWSAYVGEGAIRFYLPLDQQLQNNFYGQLVIVTKDLEARERVAARLRDRLRKDYVGISTYVQPLEMGPPVGRPIQYRVSGPQIDKVREYAMGLAGVLDGNPNIGDIVYDWNEPGKMLKIDIAQDKARQLGLSSEDVAQIMNSVVTGSAVTQVRDDIYLVNVIGRAEDSERGSLETLESLQIVTPSGTSIPLKAFAKVSYELEQPLVWRRDRKPTITVKASLRGEIQPTDLVARLAPEVKRFADGLPANYRIEVGGTVEESGKAEGPIAKVVPLMLFLMATFLMIQLQSVQKLFLVASVAPLGLIGVVAALLPTGTPMGFVAILGILALIGIIIRNSVILVTQIDAFEKDGKTPWEAVLEATHHRTRPILLTAAAASLGMIPIAREVFWGPMAYAMIGGIVAATLLTLIFLPALYVAWYRIPEPGR	20.10	gnl|BL_ORD_ID|2049|hsp_num:0	2194		
BGC0000723.1|Validamycin_5 # 3656 # 4231 # -1 # ID=1_5;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=5bp;gc_cont=0.759	BGC0000723.1|Validamycin_5 	3656	4231	-	Loose	1200	26.9498	arnA	28.33	3002985	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	GTGTTCACGCGCCGCGCGAAGGTCGTGAACGGCAGCTCACACTCCCCGCCGGCCGGCCGGCAACGCCACCACACGCTGGACCTCGGAGCCGGCGGCATCGAGCGCGTGCACCAGGTCGCCGTCGAAGCGCAGCAGGCCGCGGACACTGCCGCCGACACCGCGCAGCCCCTCGTTCGGCAGCCGTCCGCCCCACTCCCCCTGCTCGCGGTGCAGTCGCCGCTCCTCCTAGGCCCGTTCCTCCGCCTGGCGGGCCAGGCCCCGGAGAGTGCCAGGTCGACACGTCTTTCGTGCGAGGCGCCCCGAGGCGCCGGCTCCTCACGGACGGTCCGCGGCAGTGGCGGCGGGCGTGGGCCATGCTCCGTGGCGGGCAGCGCGTCGGATGGTGGGAAGGCACCGGGGGTCTCCTCGCCGGGCGCGGCGCCGCGACGCGTGACGAGCCGCGTGACGAGCGGGGCGCTGGGGCGCGGACTAGCCTGGACAGCAGTCGGGCGGCCGTGTCGGCCGAGAGGTCATCCCGACACCGATCCTGCGGCCGGCGGACGCGTGGCGGTGTCCGCGGCCCCGAATTCCTCCTGA	MFTRRAKVVNGSSHSPPAGRQRHHTLDLGAGGIERVHQVAVEAQQAADTAADTAQPLVRQPSAPLPLLAVQSPLLLGPFLRLAGQAPESARSTRLSCEAPRGAGSSRTVRGSGGGRGPCSVAGSASDGGKAPGVSSPGAAPRRVTSRVTSGALGRGLAWTAVGRPCRPRGHPDTDPAAGGRVAVSAAPNSS	MTSKAVVFAYHDIGCTGIEALLNAGYEIAAVFTHADDPRENTFYASVARLCAERGIPLHAPEDVNHPLWLERIRQLRPDFLFSFYYRRLLGAELLACAARGAYNLHGSLLPRYRGRAPANWVLVNGETQTGVTLHRMIERADAGPILAQQAVAIDPEDTALSLHGKLRKAAGALLRDSLPLLALGVLPEVEQDESQASHFGRRTPADGLLDWHRPARQLYDLVRAVTQPYPGAFCQVGEQKLIVWSAEVVAGNHGREPGSVLSCDPLRIACGEDSLVLRFGQRGERGLYLAGTQLATELGLVEGARLRGAACSPQRRTRVLILGVNGFIGNHLSERLLRDGRYEVHGMDIGSDAIERLKADPHFHFVEGDIGIHSEWLEYHVKKCDVILPLVAIATPIEYTRNPLRVFELDFEENLRIVRYCVKYGKRVVFPSTSEVYGMCQDPDFDEDRSNLVVGPINKQRWIYSVSKQLLDRVIWAYGQQGLRFTLFRPFNWMGPRLDRLDSARIGSSRAITQLILHLVEGTPIRLVDGGAQKRCFTDVDDGIEALARIIDNRDGRCDGQIVNIGNPDNEASIRQLGEELLRQFEAHPLRAQFPPFAGFREVESRSFYGDGYQDVAHRKPSIDNARRLLDWQPTIELRETIGKTLDFFLHEALREREAQA	28.85	gnl|BL_ORD_ID|1549|hsp_num:0	1643		
BGC0000723.1|Validamycin_6 # 4698 # 5795 # -1 # ID=1_6;partial=00;start_type=ATG;rbs_motif=AAGG;rbs_spacer=7bp;gc_cont=0.679	BGC0000723.1|Validamycin_6 	4698	5795	-	Loose	400	27.335	IND-3	28.57	3002259	protein homolog model	n/a	n/a	carbapenem	antibiotic inactivation	IND beta-lactamase	ATGACCGGAAGTGTTCCCATCGTCGACCTGGAGGCATGGCGGGCAGCCGACGAGGAGAACCGGGCGTCCCTGGCCGAGATCATCGACGGCGCCCTGCACACCGTGGGCACGTTCCTGTTGGCGGGCCACGGCGTGCCTGCGGAGCTGACCGCGCGCATGCGCACAGCAGGGCGCTCCTTCTTCGACCTGCCGTGGGAGAAGAAGGAGCCTCACGCCGTACAGCGCCCGCACGACAATGGCTGGCGCGGCCTCGTGAAGCACCGGACAGACACAATCGAGGGCACGGGAGGTGCCCCTGATCTGCACGAGGCGTTCCACATGGGCCCGACCCACCGCACCGGAGACGACGCCTTCGACGCCCTGTACTACCCCGCCAACAAGTGGCCGGCGGAACTGCCTGAGCTTCGAGAGACGGCCCTCGCCTACACGGCCCACATGACACGGGTCGCAGGCGCGGTCATGGAGATGCTGGCCGGGGTACTGGGCCTCGAACCCGCCTTCTTCACGTCCCGGTGCGAGCATGCCACCTGGACCCAAAGCGTCAACTGGTACCCGTCGCTGGACACTGTCGGCCAGACGGCCGAGGGACAGATGCGAGTCGGACCGCACACCGACTTCGGCACCATCACTCTTCTGGACCGCCAGCAGGGCGTCTCCGGGCTTGAGGTGTGGAGCGAGGAAGACGGCTGGTTCGCGCCGCCGTTCGTGGAGGGAACCTTGCTGGTGAACCTGGGCGACCTGATGCACCAGTGGACGGACGGCCGATGGCGCTCGCTGCGGCACCGTGTGCTTGCTCCCAGTGCGAGCGCTCCGCAAGAGGAACTGGTTTCCCTCGTCTACTTCTTCGATGCGGACCCCGAAGCGGAGCTCGTGCCGCTCGCCGCACCGGTCGGCGGCGGCGCGGGCATGCCCACCGTGAACGTCGGCGAGACGATCCTGAAGAAGAACATCCAGATGCTGACCGACCTGAAGGGCCACGGGCTCTTCCAGGGCGAACTGTCCCTGTCCCGTCCTGGCTCCGCCGACAGCCCTGGAAGCAGCCCGGCCGACGATCACCCATCGCGTCCCGGGCGTCACCCCGCTCAGGGTCCGCAGTGA	MTGSVPIVDLEAWRAADEENRASLAEIIDGALHTVGTFLLAGHGVPAELTARMRTAGRSFFDLPWEKKEPHAVQRPHDNGWRGLVKHRTDTIEGTGGAPDLHEAFHMGPTHRTGDDAFDALYYPANKWPAELPELRETALAYTAHMTRVAGAVMEMLAGVLGLEPAFFTSRCEHATWTQSVNWYPSLDTVGQTAEGQMRVGPHTDFGTITLLDRQQGVSGLEVWSEEDGWFAPPFVEGTLLVNLGDLMHQWTDGRWRSLRHRVLAPSASAPQEELVSLVYFFDADPEAELVPLAAPVGGGAGMPTVNVGETILKKNIQMLTDLKGHGLFQGELSLSRPGSADSPGSSPADDHPSRPGRHPAQGPQ	MKKRIQFFMVSMMLSSLFSAQVKDFVIEPPIKKNLHIYKTFGVFGGKEYSANSVYLVTQKGVVLFDVPWEKVQYQSLMDTIQKRHNLPVIAVFATHSHDDRAGDLSFFNNKGIKTYATSKTNEFLKKDGKATSTEIIKTGKPYRIGGEEFVVDFLGEGHTADNVVVWFPKYNVLDGGCLVKSKAATDLGYIKEANVEQWPKTINKLKSKYSKASLVIPGHDEWKGGGHVKHTLELLNKK	152.72	gnl|BL_ORD_ID|629|hsp_num:0	670		
BGC0000723.1|Validamycin_7 # 6239 # 7750 # -1 # ID=1_7;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.725	BGC0000723.1|Validamycin_7 	6239	7750	-	Loose	200	33.113	FosK	27.66	3003207	protein homolog model	n/a	n/a	fosfomycin	antibiotic inactivation	fosfomycin thiol transferase	GTGGACGAAGTGGCAGCCGCCGTCACGCCCGCGCTCCTGCCGGTACGCGGGCAAGGCGGTACGCGAGCAGGGCCGCACACAGCCGCCTGGCCGCGCACTCGGCCTCGCGCCCTGCGGGTCCGCGGGGTTCGCGAGGCGCCCGCCACCCGTCGCGCGCCCGCGGTCCGCAAGGGACGGCTCGCAGCGAGCGGTCCATCACCTAGCCTGAGGAGGCAGCCCGTGCTCTTCTCCGACCGCCCGAACACACGTGAAGGAGCCTCGCCCGGTTCCGCCGAAGCCGGCATGTCCTCGTGTGGCGACGGCCAGGAACCGCGCCCGCCCGGGGTGCCCGGCGCCCAACGAGTCGACCATCTGGCGTTCACTGTGTCCGACCTGGATGCCGCGATCGATTTCGCCGTCATGGCACTCGGTGGCGAACTCGTCTACCGTCTGCCGCCCTTGGCGCACACCGACGGCTGGATGCGCACACACCTCGACGTACACCCCCGAGCCAGCGCCGAGATCGCCCTCGTCCGCCTGGGCCCCGACACCAACCTCGAACTGTTCGCCTACAAGTCGCCGGATCACACCGCCGCGCCACGAGCACCACACGACACCGGGCACGTGCACCTGGCGCTGCACGTGACGGACGTGGCACGGGCGGCCGCCGAGCTCACGCGTCGCGCGGGGGTGAGCCCGCTCGGCCCCGTCCTCCGTGTCCCCGACGGACAGCCCGACGCGGGCACACACTGGGTCAGGCTTTCCTCGCCCTTCGACGCGCCCCTCGAACTGCGGTCGGTACCGGACGTGTTGCCGTACGAGGCCGTCGGCGGCACACCACGCCGCCGCCCGCCGGGGCCATGGCGCAACCGGGACGACGGTACGGGAAGCCGGCACGGCCTTCCCGGCGCGCTCGGTGTCGACCACTTCGCCAGGACCGTCGCGGACCTCGACTCGGCCGAGCGGTTCTTCGTGGACGTCCTGGGCGCCGAGCCTCTGTACCGAAGCGAGTACGGGGCCCTTCCCGAGGATGTGGCGGCGGCCCTCGGCGTGCCACCGGGCGGTGCGATGCGGCGGGCCGTACTGGGCATGGGCCCGACCGATACCATCGAACTGGCAAGCTACCAGGGGAAGTCGGCCGGCAACCCACGCCCTCCGCGCAACAGCGACGTCGGCGGCAGCCATATCGCCCTGCACGTCCGTGACGTGGACGCCGCTGCCGCCTACCTGGCCGCGCACGGCTGTACCGTGCTCGGCCGGCCGGAGACGATCGACGAAGGGCCGCTTACCGGCGACCGATGGGTGTACACACGCGCCCCGTGCGGCCTCTATGTGGAAGTGGTGCGCATGCCGGACGGCGCACTGCCCTACGAACGCGGTACCGCTGCCCGGCGCAAGGCCGCACATGGGCTGTCATGGACCGACCGTACGCCACCCCGGCCCGTTCGGGGCACCGTGCCTGACAGCCCGGGGACGGACACATCGAGCACCCAGCGGCACCCCCAGGGGAGAGGAACCTCGTGCCGTCCGTGA	MDEVAAAVTPALLPVRGQGGTRAGPHTAAWPRTRPRALRVRGVREAPATRRAPAVRKGRLAASGPSPSLRRQPVLFSDRPNTREGASPGSAEAGMSSCGDGQEPRPPGVPGAQRVDHLAFTVSDLDAAIDFAVMALGGELVYRLPPLAHTDGWMRTHLDVHPRASAEIALVRLGPDTNLELFAYKSPDHTAAPRAPHDTGHVHLALHVTDVARAAAELTRRAGVSPLGPVLRVPDGQPDAGTHWVRLSSPFDAPLELRSVPDVLPYEAVGGTPRRRPPGPWRNRDDGTGSRHGLPGALGVDHFARTVADLDSAERFFVDVLGAEPLYRSEYGALPEDVAAALGVPPGGAMRRAVLGMGPTDTIELASYQGKSAGNPRPPRNSDVGGSHIALHVRDVDAAAAYLAAHGCTVLGRPETIDEGPLTGDRWVYTRAPCGLYVEVVRMPDGALPYERGTAARRKAAHGLSWTDRTPPRPVRGTVPDSPGTDTSSTQRHPQGRGTSCRP	MITGINHITFSVRDLSSSIEFYRDLLGMRLHVTWEAGAYFTAGDTWVCLSVGEPKPANDYTHVAFSVGERELVELHARLKEAGVEEWKQNTSEGNSVYLLDPNGHRIELHCGTLATRLAELEKSPYKRLVWC	381.06	gnl|BL_ORD_ID|1606|hsp_num:0	1703		
BGC0000723.1|Validamycin_8 # 7917 # 8345 # -1 # ID=1_8;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.762	BGC0000723.1|Validamycin_8 	7917	8345	-	Loose	700	25.0238	OmpA	56.0	3005044	protein homolog model	n/a	n/a	monobactam; carbapenem; cephalosporin; cephamycin; penam; penem	reduced permeability to antibiotic	General Bacterial Porin with reduced permeability to beta-lactams	GTGACCACGCTGCTCCTGGGCAGCGACTCCGTCGGCGGTGCGCCGGCCACGGCACTGGCGTGGGCGAGGGAAGCAGTCGCGGGCACCTTCGGGACCCGCCCGAGGGCCGGCACACTCGCCGCCGGCGTCCGGTGGGGACGGCTCGACGTGACGCGGCCCGGGGGCCTCCCGCTGGTGCCGGCCGGCCGCGGAGCCGGGCGGGCCGTCCTCGCGCACGGCCCGCCAGACGTCCTGGTGCGAGTGGCAACCGCCGGAAGCCGTGACGGGGCATGTCGTGGCGGCGCGGCCGGTGGCGATGGTCCGGCGGCCTGTGATGCCGACCTCCACGGGCAACGTCCTCGACGCAGTGGTCTGCGCGCTGTCCGGCACATGACGCGTACGACACCGGCGACCCCGTACGCCGGTACGAAACCAGCGGCGGAACAGTAG	MTTLLLGSDSVGGAPATALAWAREAVAGTFGTRPRAGTLAAGVRWGRLDVTRPGGLPLVPAGRGAGRAVLAHGPPDVLVRVATAGSRDGACRGGAAGGDGPAACDADLHGQRPRRSGLRAVRHMTRTTPATPYAGTKPAAEQ	MRSFVTSWRILDDNEAQKMKKTAIAIAVALAGFATVAQAAPKDNTWYAGGKLGWSQYHDTGFYGNGFQNNNGPTRNDQLGAGAFGGYQVNPYLGFEMGYDWLGRMAYKGSVDNGAFKAQGVQLTAKLGYPITDDLDIYTRLGGMVWRADSKGNYASTGVSRSEHDTGVSPVFAGGVEWAVTRDIATRLEYQWVNNIGDAGTVGTRPDNGMLSLGVSYRFGQEDAAPVVAPAPAPAPEVATKHFTLKSDVLFNFNKATLKPEGQQALDQLYTQLSNMDPKDGSAVVLGYTDRIGSEAYNQQLSEKRAQSVVDYLVAKGIPAGKISARGMGESTPVTGNTCDNVKARAALIDCLAPDRRVEIEVKGYKEVVTQPAA	37.97	gnl|BL_ORD_ID|2833|hsp_num:0	3787		
BGC0000723.1|Validamycin_9 # 8342 # 9397 # -1 # ID=1_9;partial=00;start_type=GTG;rbs_motif=AAG;rbs_spacer=10bp;gc_cont=0.723	BGC0000723.1|Validamycin_9 	8342	9397	-	Loose	750	27.335	CMH-1	29.82	3004777	protein homolog model	n/a	n/a	cephalosporin	antibiotic inactivation	CMH beta-lactamase	GTGACGGCACTTACCCCCGCGCCGTGTGACCTCGTGGTGGCCGACCTCGGTGGCACGACCCTGCGCGTGGGCCGCATCACGGCGGGCACGTCCGAAGTGCACGACGTGAAGCGTGTGCCCACCAACGGGCTCGGTCGGTACGGCGCACTCGCCCCGCAGGAGCTCCAGGACCGCGTCATGGAACAGCTCACGCGGGAGATCGCGGCCCACCTGAACCGTCCGGGTCAAGCACCCGCTCAGGCTGTCGCCGTGTCCTTCGCCGGGCCGATGACAGCCGACGGAGTCGTCCTCGCCGGCCCGACACTGTGGGGAGGACCCGCGGCCCCGCTGCCCGTCGCCGATGTGTTGACCCAACAGCTGGGTCTGCCCGTGGTCGCGGCCAACGACGTGACCGCGGCGGCTTGGCGATACGCCGCGGCCGAGCCCGAGCCGTTCTGCCTGACCACCGTGAGCTCGGGCATCGGAAACAAGGTCTTCCGCCATGGCGAGATCGTCATCGACCAGCTCGGGTACGGAGGCGAGATCGGCCACTGGCTCGTCGATCACGCTGAGGACGCCGCGCCATGCGAGTGCGGAGGGCGCGGCCACCTCGGGGCGATCGCGTCAGGACGCGGCGCCCTGTTCGCGGTGCGCGCGGCGGCGGCAGCCGACGCCAGTGCCTTCGCGCGCTCCGCGCTGGCCGGGCCGTCGGGCGGCGTGCCCGAGGCCATCACCAACGAGGCGTTCGCGGCGGCGGCCCGAGCAGGCGACACGTTCGCGCGGGAGTCGCTGCGCCGCTCGCTGCGGCCCCTCGCGTCCGCGGTGAGCTTGCTGTTCACCGCGATCGGGGTGCGCCGTTACCTGTTCGTGGGGGGCTTCGCCCTCGCCTTGGGCGACACCTTCCTGACGTTGCTCGGTGACGAGTTGGTGCGGGTCGGCTGCTTCGGCTTGGACGAGTACGCGACGCGCGCCATGCTCGCGCTCGGTGAGGATGACGACGACCACTGCCTCATCGGCATCGGTCAGTTGGCGGCGGCCCGCCTCGGCGCTCCCCGGGCCGTCGAGGTGACGGCGTGA	MTALTPAPCDLVVADLGGTTLRVGRITAGTSEVHDVKRVPTNGLGRYGALAPQELQDRVMEQLTREIAAHLNRPGQAPAQAVAVSFAGPMTADGVVLAGPTLWGGPAAPLPVADVLTQQLGLPVVAANDVTAAAWRYAAAEPEPFCLTTVSSGIGNKVFRHGEIVIDQLGYGGEIGHWLVDHAEDAAPCECGGRGHLGAIASGRGALFAVRAAAAADASAFARSALAGPSGGVPEAITNEAFAAAARAGDTFARESLRRSLRPLASAVSLLFTAIGVRRYLFVGGFALALGDTFLTLLGDELVRVGCFGLDEYATRAMLALGEDDDDHCLIGIGQLAAARLGAPRAVEVTA	MMTKSLSCALLLSVACSAFAAPMSEKQLADVVERTVTPLMKAQAIPGMAVAVIYQGQPHYFTFGKADVAANKPVTPQTLFELGSVSKTFTGVLGGDAIARKEISLADPVTKYWPELTGKQWQGIRLLDLATYTAGGLPLQVPDDVTDNASLLRFYQSWQPKWAPGTTRLYANTSIGLFGSLAVKPSGMCFEQAMAERVFKPLKLNHTWINVPHAEEPHYAWGYREGKAVHVSPGMLDAEAYGVKSNVKDMASWVMANMAPETLPQSTLQQGIALAQSRYWRVGAMYQGLGWEMLNWPVDAKTVVDGSDNKVALAPLPVAEVNPPAPPVKASWVHKTGSTGGFGSYVAFIPEKQIGIVMLANKSYPNPVRVETAYRILDALQ	92.13	gnl|BL_ORD_ID|2700|hsp_num:0	3576		
BGC0000723.1|Validamycin_10 # 9394 # 10467 # -1 # ID=1_10;partial=00;start_type=ATG;rbs_motif=AAGG;rbs_spacer=7bp;gc_cont=0.686	BGC0000723.1|Validamycin_10 	9394	10467	-	Loose	930	28.4906	Mycobacterium tuberculosis rpsA mutations conferring resistance to pyrazinamide	25.62	3004721	protein variant model	I351F	n/a	pyrazinamide	antibiotic target alteration	pyrazinamide resistant rpsA	ATGGGGCCGCTGGGACGCGGCAGGCTCAAGCCGCTGGTGCCGTTCGGCGGCACCTCCCGGCTCATCGATTTCAGCATCGCCAACGTTCACCGGTCGGGCCTGCGGGACGTCCTGCTGCTGTCGCAGTACGAGGAGCGCCGCCTCATGGACGATCTGCACCTGGTCTGGAACGGGCGCCACCGCGGCTTCCGGATAGATTTCGGCCCCTATGACGCGGTGTACCGGCGCTCACCGGGCAAGCTTCCCGAGCAACTGCCGGAGCGTATCTGGCCGTTGGAACGCGGCACAGCCGACGCGCTGCTCACCAAGGCCGAGTACGTCTTCAGGCAGGGTGACGCAGAGGCCTCGGAGATCCTCGTGCTCCACGCGGACCACGTCTACCGTTTCGACTACGGCGACATGATCCGCGAGCACCGCGCGTCCAAGGCCGCGCTGACAGTGTCGTACCAGCGCATCGAGCGGCGGTACGTGCACCTTTTCGGCATGGTCGAGTTCGACGGGGACGGCCTGCTCACAGCGTTCGAGGAGAAGCCTGACGACCCCACGAGCGACCTGGTGTTCGCCGCCTTCTGCCTCTTCGACGCGGCGACTCTGCGGCGTTACCTGGAGCAACTGCGCGGCACGGATTGGCAGCACGACATCAGCAGGGACGTCATCCCGGCGATGCTGGCGGGCGGCGAACTCATCCGCGGGTATGAGGTCAAGAGCTACTGGGAGGACATCGGCACCGTGGACCGCTACCACCGCGCCCATCGCGGACTGCTGCGGGCGGATCCGACGCTCGCGTTGAGCGACATGCCGCTGACCGTCGCCCCCGAGGTGCCACGGCACCTCGTCCCGGGCGGGCCCGGCCGGCGTGCCAGCGTCGTGGCGGCCGACGTGGCGAACGAGGGCGAGATCGTGAGCAGCGTGGTGTACCCGGGCGCACGCATCGGTGTTGACGCACACGTGGTCGACTGCGTCGTGCTGCCAGGCGCCCGGGTACCGGACGGAACACACCTGGCGTCGGCCATCGTGCTGGAGGACGGCTCCGTCCAGCAGTGCGAGGCGGAGCGGGAAGAGGTGGCGCTGTGA	MGPLGRGRLKPLVPFGGTSRLIDFSIANVHRSGLRDVLLLSQYEERRLMDDLHLVWNGRHRGFRIDFGPYDAVYRRSPGKLPEQLPERIWPLERGTADALLTKAEYVFRQGDAEASEILVLHADHVYRFDYGDMIREHRASKAALTVSYQRIERRYVHLFGMVEFDGDGLLTAFEEKPDDPTSDLVFAAFCLFDAATLRRYLEQLRGTDWQHDISRDVIPAMLAGGELIRGYEVKSYWEDIGTVDRYHRAHRGLLRADPTLALSDMPLTVAPEVPRHLVPGGPGRRASVVAADVANEGEIVSSVVYPGARIGVDAHVVDCVVLPGARVPDGTHLASAIVLEDGSVQQCEAEREEVAL	MPSPTVTSPQVAVNDIGSSEDFLAAIDKTIKYFNDGDIVEGTIVKVDRDEVLLDIGYKTEGVIPARELSIKHDVDPNEVVSVGDEVEALVLTKEDKEGRLILSKKRAQYERAWGTIEALKEKDEAVKGTVIEVVKGGLILDIGLRGFLPASLVEMRRVRDLQPYIGKEIEAKIIELDKNRNNVVLSRRAWLEQTQSEVRSEFLNNLQKGTIRKGVVSSIVNFGAFVDLGGVDGLVHVSELSWKHIDHPSEVVQVGDEVTVEVLDVDMDRERVSLSLKATQEDPWRHFARTHAIGQIVPGKVTKLVPFGAFVRVEEGIEGLVHISELAERHVEVPDQVVAVGDDAMVKVIDIDLERRRISLSLKQANEDYTEEFDPAKYGMADSYDEQGNYIFPEGFDAETNEWLEGFEKQRAEWEARYAEAERRHKMHTAQMEKFAAAEAAGRGADDQSSASSAPSEKTAGGSLASDAQLAALREKLAGSA	74.22	gnl|BL_ORD_ID|2320|hsp_num:0	3403		
BGC0000723.1|Validamycin_11 # 10520 # 11758 # -1 # ID=1_11;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=9bp;gc_cont=0.681	BGC0000723.1|Validamycin_11 	10520	11758	-	Loose	1850	25.0238	mdtF	45.0	3000796	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; penam	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCAAGCAGAGTTCCTTATCCCCCGGTAGCCGCCTGCACGACTACACCACGCAGGACGGCGCGGCCTGGCGGGTGAGCGCGCTCAAGGAGGTGAGCTACGACGTCATGGTGCAGCCGCGGCTGCTCGATCCGGCGAATCCGGCGCTCGCCGACGCCCTCTCGTCCGGGACGACGCCTGCGCGCCGGCTCATCGTGATAGACGCTACGGTGCGCTCCCTCTACGGCGAGCAGCTTGCCGCCTACCTGGCGGGCCACGACGTGGAGTTCCACCTGTGCGTCATCGACGCACACGAGTCGGCAAAGGTCATGGAGACCGTCTTCGAAGTCGTGGACGCGATGGACGCCTTCGGTGTGCCACGGCGCCACGCACCGGTGCTCGCCATGGGTGGCGGGGTGCTCACGGACATCGTCGGTCTTGCGGCGAGCCTGTACCGCAGGGCCACGCCGTACGTCCGCATACCCACGACCCTGATCGGGATGATCGACGCGGGCATCGGCGCCAAGACAGGTGTCAACTTCCGTGAGCACAAGAATCGGTTGGGCACGTATCACCCCTCCTCGCTGACCCTCATCGATCCCGGCTTCCTCGCCACACTCGACGCCCGACACCTGCGCAACGGTCTGGCGGAAATCCTGAAGGTGGCCCTGGTCAAGGATGCCGAACTGTTCGATCTGCTGGAGGGGCACGGCGCGAGCCTGGTCGAGCAGCGGATGCAACCGGGCGAGGGCGGGACGGGCGGTGCGGCGCTCACAGTGCTGCGCCGGGCGGTCCAGGGCATGCTGGAGGAGCTCCAGCCCAATCTCTGGGAGCACCAGCTGCGGCGCCTGGTGGACTTCGGCCACTCCTTCTCACCCAGCGTGGAGATGGCGGCGCTGCCCGAGTTGCTGCACGGTGAGGCCGTCTGCATCGACATGGCGCTCAGCTCGGTGCTCGCCCATCACCGTGGGCTACTGACCGAGGCCGAGCTCGGCCGTGTCCTCGATGTCATGCGTCTGCTCCACCTGCCTGTGCTCCACCCGGTGTGCACGCCGGACCTCATGCGCGCGGCGCTCGCGGACACGGTCAAACACCGGGACGGCTGGCAACACATGCCCCTTCCACGCGGGATCGGCGACGCCGTGTTCGTGAACGACGTCACTCAACGGGAGATCGAGGCCGCGCTTCTCACACTCGCCGAGCGGGACCGGGTGCCGCGGTGGCGGGCGCTGCACGGTGCCGTGGACATGGGGGTGTGA	MTKQSSLSPGSRLHDYTTQDGAAWRVSALKEVSYDVMVQPRLLDPANPALADALSSGTTPARRLIVIDATVRSLYGEQLAAYLAGHDVEFHLCVIDAHESAKVMETVFEVVDAMDAFGVPRRHAPVLAMGGGVLTDIVGLAASLYRRATPYVRIPTTLIGMIDAGIGAKTGVNFREHKNRLGTYHPSSLTLIDPGFLATLDARHLRNGLAEILKVALVKDAELFDLLEGHGASLVEQRMQPGEGGTGGAALTVLRRAVQGMLEELQPNLWEHQLRRLVDFGHSFSPSVEMAALPELLHGEAVCIDMALSSVLAHHRGLLTEAELGRVLDVMRLLHLPVLHPVCTPDLMRAALADTVKHRDGWQHMPLPRGIGDAVFVNDVTQREIEAALLTLAERDRVPRWRALHGAVDMGV	MANYFIDRPVFAWVLAIIMMLAGGLAIMNLPVAQYPQIAPPTITVSATYPGADAQTVEDSVTQVIEQNMNGLDGLMYMSSTSDAAGNASITLTFETGTSPDIAQVQVQNKLQLAMPSLPEAVQQQGISVDKSSSNILMVAAFISDNGSLNQYDIADYVASNIKDPLSRTAGVGSVQLFGSEYAMRIWLDPQKLNKYNLVPSDVISQIKVQNNQISGGQLGGMPQAADQQLNASIIVQTRLQTPEEFGKILLKVQQDGSQVLLRDVARVELGAEDYSTVARYNGKPAAGIAIKLAAGANALDTSRAVKEELNRLSAYFPASLKTVYPYDTTPFIEISIQEVFKTLVEAIILVFLVMYLFLQNFRATIIPTIAVPVVILGTFAILSAVGFTINTLTMFGMVLAIGLLVDDAIVVVENVERVIAEDKLPPKEATHKSMGQIQRALVGIAVVLSAVFMPMAFMSGATGEIYRQFSITLISSMLLSVFVAMSLTPALCATILKAAPEGGHKPNALFARFNTLFEKSTQHYTDSTRSLLRCTGRYMVVYLLICAGMAVLFLRTPTSFLPEEDQGVFMTTAQLPSGATMVNTTKVLQQVTDYYLTKEKDNVQSVFTVGGFGFSGQGQNNGLAFISLKPWSERVGEENSVTAIIQRAMIALSSINKAVVFPFNLPAVAELGTASGFDMELLDNGNLGHEKLTQARNELLSLAAQSPNQVTGVRPNGLEDTPMFKVNVNAAKAEAMGVALSDINQTISTAFGSSYVNDFLNQGRVKKVYVQAGTPFRMLPDNINQWYVRNASGTMAPLSAYSSTEWTYGSPRLERYNGIPSMEILGEAAAGKSTGDAMKFMADLVAKLPAGVGYSWTGLSYQEALSSNQAPALYAISLVVVFLALAALYESWSIPFSVMLVVPLGVVGALLATDLRGLSNDVYFQVGLLTTIGLSAKNAILIVEFAVEMMQKEGKTPIEAIIEAARMRLRPILMTSLAFILGVLPLVISHGAGSGAQNAVGTGVMGGMFAATVLAIYFVPVFFVVVEHLFARFKKA	39.73	gnl|BL_ORD_ID|106|hsp_num:0	121		
BGC0000723.1|Validamycin_12 # 12764 # 12961 # -1 # ID=1_12;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.606	BGC0000723.1|Validamycin_12 	12764	12961	-	Loose	1700	22.3274	LpeB	45.16	3004100	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGAGACCATATTGCCCTCGCGCCCAATTAGGGCGATCGGCCGATGGCCTTGTCCGTCTCCGCCGCTTCTTCAACAGTTCCGTCGAGCCGGACGGGTTATGGCGTGAATCCGCTACTCGTGGACACGACCGCAACAGCACGGTACGGCGACGCAGGAGACCCGTATTTTGTCGATGCCGCTCCACTCAACGCCAGTGA	MRPYCPRAQLGRSADGLVRLRRFFNSSVEPDGLWRESATRGHDRNSTVRRRRRPVFCRCRSTQRQ	MKLTSYFIKHPVITIILNAMIVVLGLLCLYNLSVREYPDINFPTITVSASYPNASPDLVETAITNVLEDRLAGIEGLETITSQSSAGYAQITLMFRSGTSMDRALSTTQDAVGVAKALLPPEVRSPTVERQRKSNGLPFIGISLESTSKDFGELTHYANLNLKNVFRSVQGVASVEVWGQPYTYNITLQPEKLFSFGVNVDEIVNALAKNRISLPAGNYRNKIPSTLNSELKTREDYENLLIKANSKHPILLKSLANVALETDNSQMRVRVNGHAGVVLSINKANEANPIEVSKEIRKVIKGLQQGLPKDLKINTIIDQSDFINASIKNIRSAIGEAIFLVLIIVFLFLRNIKATIIPLITIPISLLGSLLFLKLFGFSINLMTLLAMVLAIGLVVDDAIIVLENIWRHIESGLSPLDAALKGAREIGFAIIAMTFTLSSVYLPIAFIQGMLGQLFVEFAVALAGSVFISGIVALTLSPLMCANLLSASSKNWWPQFDNALEKLTKHYSNILQFILKHQKITLLTALISVVACFGFYNLISHETAPKEDRGLIGIYIPPVAGEDIGMLDNKTGKLEKKLDAIPEANNRLTFIGDWGGSIVLPLKPHAQRHRSANQIVEKLRPSFNHFPSMDPHVWSWDTGLPGVDDAGSGSELTLVISTPDHFRQLFDETEKLKSVLDKSKLFAAVNYDLRLDTMGYNIDLDYNQLAKLGLTANQVAKTIEVFFSGDKSQTFEKDGVVYNISIKGDSSPWTLNELYLTTNEGKSVSLGAITKMQPKAQPATLDHYQQMRSTTLHVQLHKGDSMAKAIEKLWGTTKEVMPQHYKLTWIGAAKAFHESSNSMLFLFFLSLAFIYAILCTQFENFTDPFIILFTVPLACSGALLFTYLFGQSLNIYTQVGLITLIGLISKHGILIVEFANKLHKDGASLPEAIQKSAALRLRPILMTTGAMVFGAIPLVLSHDAGSESRHAIGTVLISGLGLGTLFTLFVLPAVYNIIKSKLIDMQKTGGKKRCSKE	6.41	gnl|BL_ORD_ID|2454|hsp_num:0	2759		
BGC0000723.1|Validamycin_13 # 13101 # 13235 # -1 # ID=1_13;partial=00;start_type=ATG;rbs_motif=AAGG;rbs_spacer=6bp;gc_cont=0.652	BGC0000723.1|Validamycin_13 	13101	13235	-	Loose	750	21.1718	tet(52)	38.89	3004587	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	ATGTGTTTCCTCCGGCTGATGTGGCGGGCTGACATGGCGGAAACGTGTGCCGATCGGGTGAACGGGCGTCCAGTGCAGTCGCACACGTGGGTTCCCCGGCCGGTGCCGCCGTTGAGCGCGCCTGATGGTTCGTGA	MCFLRLMWRADMAETCADRVNGRPVQSHTWVPRPVPPLSAPDGS	MSNVNKILVIGAGIAGPAACYWLRRFGFSPVLVERSASLRKGGHALDVRGVAIDLVKRMGIYQKIYNMRTQLEFGRHVDPEGNTLHEEKGERFGFREGQDVEIIRSDLVEILIDSIEGVPLQFNQTIESVKQTDAVVEVQFKDGRTEHFDLVIGADGLHSTTRRIVFDKHEYKLNDLGAYFSVFSIPNYLNLNNTEVQCEANQKLLSITSDKNRKMAEVAFSFRGQNVLNNVRDESEQRRVLRDTFQDFGWEAPRILELMSDSDDFYSDSFTQVIMKSWTKGRVALLGDAAYSASPISGQGNNLALVGAYVLAGELKQAGGNYKRAFDRYNEILRPFIEANQKLGVLVNESFLVRDEVSKEVAEERSNNIMEQVKIASNMIVLQDYANPH	11.28	gnl|BL_ORD_ID|2756|hsp_num:0	3289		
BGC0000723.1|Validamycin_14 # 13291 # 14175 # 1 # ID=1_14;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.690	BGC0000723.1|Validamycin_14 	13291	14175	+	Loose	750	26.1794	tet(53)	25.0	3004589	protein homolog model	n/a	n/a	tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	GTGCCTGGCCGCATCCTGATCCTCGGTTCCGGCTACCTTGCCGGGCACATCGCCGCCCGCCTCACCCGGCTCGGCGCCGAGACAGTGCTCAGCTCCCGGCGTGCCCCAGTCCTCCCCGAGAGCCGAGGTGTGCGCTGGAAGCAGGTCGATGTCACCTCGGGCCCGCAGGTGGCTGCCTTGATGGATGCCGTCGAGCCCGATGCCGTCGTGGCCGTGCACGGCCCCTCCGACATCACTTGGTGCGAGTCGCATCCCGAGGAGGCATACGCCACCCACCACGGCGGTGCCCGCAACATCGCAGCCGCACTGGACGGCCGCCCCGTCCTGCTGGTGTCGACCGACAACGTTTTCTCCGGCGAGGACGAGAGCTACGGGGAGTCAGCACAGACCTTCCCGGTCAACGCCTACGGCCGGGCGAAGCTCGCGGCCGAGCGGGAGCTGCTCGACACCTCCTCCGCTCTTGTCCTGCGTGTGAGCCTGGTCTACGGCTGGGAGGATCGCGGTCCGCGGCCCAATTTCCTGACCAGTGTGGTTCGTTCGCTGATGCGCAAGGAGCAGCTACGGATCCCCGACGACCACTGGAACACCCCCGTTCACGTCGAGGACGTGGCCGCGTGGGCGACGACACTGATGAGTTCCGGCCGCACCGGAACGCTGCACCTTGGCGGGCCGCGCCGCATCGGCCGAGTCGACTGGGCCAGACACATCGCCGAGCAGCTCGGCGTGGACCCCATGCTCATCGTGCCGACGCCGCGTATCGGCACCGCCTACGCCTGCCGGCCGCGCAACGCCTGTCTACACAGCGAGGTGGCCGCGCAGTTGCCCGAACTGCAACACCACCGCCCGGCCGACGTCCTCGAAACCACCCATGCCCTCATCTCCTGA	MPGRILILGSGYLAGHIAARLTRLGAETVLSSRRAPVLPESRGVRWKQVDVTSGPQVAALMDAVEPDAVVAVHGPSDITWCESHPEEAYATHHGGARNIAAALDGRPVLLVSTDNVFSGEDESYGESAQTFPVNAYGRAKLAAERELLDTSSALVLRVSLVYGWEDRGPRPNFLTSVVRSLMRKEQLRIPDDHWNTPVHVEDVAAWATTLMSSGRTGTLHLGGPRRIGRVDWARHIAEQLGVDPMLIVPTPRIGTAYACRPRNACLHSEVAAQLPELQHHRPADVLETTHALIS	MSTINKILVIGAGIAGPAVCYWLRRFGFSPVLIEKFANIRKEGQALDFRGVAIDIVKGMNIYEKMCNMHKQLEVGRYVDTEGNTLHEERGERFCFRQGEDVEIARGDFAEILTGAIEGIPCHFNQVIDSIKQSDDDVKVQFNDGRVEHYDLVIGADGIYSTTRGMVFDKDEYKLVNLGVCFGVFSILNYLNLSHTEVQCEANQKLISIWSHKNPKMAEVAFVFRTQNVLNNIRNKNEQQQLLRDAFQDFGWEASKILELMTGSDDFYFDSATQVKMKSWTKGRVALLGDAGYSASPLSGQGNYLALVGAYIFAGELKKADGNYTRAFSRYNELLHPLVEACHKLGVLVSESFLVPDEVSKEVAEERSNKILQEVKIVSNMISLPEYE	75.97	gnl|BL_ORD_ID|2782|hsp_num:0	3290		
BGC0000723.1|Validamycin_15 # 14265 # 15758 # 1 # ID=1_15;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.691	BGC0000723.1|Validamycin_15 	14265	15758	+	Loose	250	27.7202	FosC2	32.76	3002874	protein homolog model	n/a	n/a	fosfomycin	antibiotic inactivation	fosC phosphotransferase family	GTGACCGGATCTGAGATCTTCCTCGCCAGCAAGCGCGCGGCGATCACCTACGACACCGACCCCGCCACCGGCGAACCGCGCGCCTGGCTGGCTCCTGGCGGTACCGGCAACGTCGTCGCCGAACAGGCCGGCGTCCTCAACATCTCGTGGATCGCCAGTGCCGACTCCGAGGACGACCGTCGCGCTTCGGCGCTCAACCCTGACGGCGTGACCATGGAACTGCACTCCGGCCGGGAGATACTGGTCCGGCTCATCAGGCACGACCCCGCTGTCTTCCGCAACGTGCAGAACTTCATGACCGCCAACCTGATGTGGGCGGCGAACAACTACGGCTGGGACCGCTGGACCCAGCCGTCGTTCGGCTCCGACGCCCGCGAAGGCTGGGCGGACTTCGGCCGCTTCACGCGCGACTTCGCCGACGCCATCCTCAAGAGCTCGGCCCAGTCGGCAGACCCTGTCTACCTCGTCCACGACTACCAGCTGGTCGGGGTCCCCGCGCTGCTGCGCGAACAGCGGCCGGACGCGCCGATCCTGCTCTTCGTCCACATCCCGTGGCCGTCGGCCGACTACTGGAGGATCCTGCCCAAGGAGATCCGCACCGGCATCCTCCACGGCATGCTCCCCGCCACCACGATCGGCTTCTTCGCCGACCGCTGGTGCCGCAACTTCCTCGAAAGCGTGGCCGATCTCCTGCCCGACGCCCGGATCGACCGCGAGGCGATGACCGTCGAGTGGCGCGGCCACCGCACCCGGCTGCGCACCATGCCGCTCGGCTACAGCCCGCTCACCCTCGACGGCCGCAACCCGCAACTGCCCGAAGGGATCGAGGAGTGGGCGGACGGCCATCGGCTGGTGGTGCACAGCGGGCGCACCGACCCGATCAAGAACGCCGAACGTGCGGTGCGCGCCTTCGTCCTGGCCGCCCGGGGCGGCGGGCTGGAGAAGACCCGCATGCTGGTGCGGATGAATCCCAACCGACTGTACGTGCCGGCCAACGCCGACTACGTGCACCGGGTGGAGACCGCCGTAGCCGAAGCCAACGCCGAGCTGGGCTCCGACACCGTGCGCATAGACAACGACAACGACGTGAACCACACCATCGCGTGCTTCCGCCGGGCCGACCTGCTCATCTTCAACTCAACTGTCGACGGTCAAAACCTGAGCACGTTCGAAGCGCCCCTGGTCAACGAACGCGACGCCGACGTCATCCTTTCGGAGACCTGCGGTGCCGCCGAGGTCCTGGGCGAGTACTGCCGCAGCGTCAACCCCTTCGACCTCGTCGAGCAGGCCGAGGCCATCTCCGCCGCGCTCGCGGCCGGGCCGCGGCAGCGGGCAGAAGCCGCTGCCCGCCGTCGCGACGCTGCCCGCCCCTGGACGCTCGAAGCCTGGGTGCAGGCACAACTGGACGGACTCGCTGCGGACCACGCCGCCCGCACGGCAACCGCTGAGCGCTTCGACACCGCACCGGCAGTCTCGACACGAGCAGACCTCTGA	MTGSEIFLASKRAAITYDTDPATGEPRAWLAPGGTGNVVAEQAGVLNISWIASADSEDDRRASALNPDGVTMELHSGREILVRLIRHDPAVFRNVQNFMTANLMWAANNYGWDRWTQPSFGSDAREGWADFGRFTRDFADAILKSSAQSADPVYLVHDYQLVGVPALLREQRPDAPILLFVHIPWPSADYWRILPKEIRTGILHGMLPATTIGFFADRWCRNFLESVADLLPDARIDREAMTVEWRGHRTRLRTMPLGYSPLTLDGRNPQLPEGIEEWADGHRLVVHSGRTDPIKNAERAVRAFVLAARGGGLEKTRMLVRMNPNRLYVPANADYVHRVETAVAEANAELGSDTVRIDNDNDVNHTIACFRRADLLIFNSTVDGQNLSTFEAPLVNERDADVILSETCGAAEVLGEYCRSVNPFDLVEQAEAISAALAAGPRQRAEAAARRRDAARPWTLEAWVQAQLDGLAADHAARTATAERFDTAPAVSTRADL	MLRGLNHITIAVSDLERSVEFYTRLLGMKAHVRWDSGAYLSLEATWICLSCDEVHPSQDYCHIAFDVSEENFEPVTKKLREAHVVEWKQNRSEGLSLYLLDPDGHKLEIHSGSLQSRLESLKSKPYQGLVWL	376.52	gnl|BL_ORD_ID|1943|hsp_num:0	2060		
BGC0000723.1|Validamycin_16 # 15782 # 17056 # 1 # ID=1_16;partial=00;start_type=ATG;rbs_motif=AAGG;rbs_spacer=8bp;gc_cont=0.671	BGC0000723.1|Validamycin_16 	15782	17056	+	Loose	1950	27.335	MexB	23.74	3000378	protein homolog model	n/a	n/a	macrolide antibiotic; fluoroquinolone antibiotic; monobactam; carbapenem; cephalosporin; cephamycin; penam; tetracycline antibiotic; peptide antibiotic; aminocoumarin antibiotic; diaminopyrimidine antibiotic; sulfonamide antibiotic; phenicol antibiotic; penem	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCAACGACGAAACGCCTCCCTGCGCCGCAGGACGCGGCTCAGTACCAGCTCGGCGATATCACGCTGGTGCGCGGCGAAGGCATCCGTGCCTGGGATGCCGAGGGGCGAGAGTTTCTCGACTGCGTCTCGGGCACCTTCAACCTACTGCTCGGACACAACCACCCAGAGGTGATGGCCGCCGTACGGGAGCAGACCGAGCGGCTCGTCTTCGCCAGCTCGTCCTTCCAGACCGAACCCACCAACCGGGTCATCCAAGAACTGGCCGCCATCAGCCCGCCCAACCTCACGCGGGTCAACCTGCGCAGCTCCGGTGGCTCCACCGCCAACGAAGGCGCCATCAAGATGGCCCAGCTCCACACCGGTCGCCGCGATGTCATCGTGCCGTTCCGCGCCCACCTCGGTCAGAGCCTCGCGACGGCCAGCCTCAACGGCACCACGAAGATGCGCGCACCCTTCCCGCACCGCTATCCCGGCGGCCTTCACGTGCCAGGCCCTTACTGCTTCCGCTGCTTCTACCGCCAGACTCCCGAGACCTGCGGGATGCTCTGTGTCGACCGCATCGAGGACTTCATCACCTATGCCAGCTCCGGCAGCGTGGCCTGCGTAGTGATCGAGCCGATCAGCGGTGCCGGCGGTAACATCGTCCCACCCGCCGGTTACCTTCAGGAGCTGCGCCGGTTCTGCGACGAGCGCGAGATCGTCCTCATCTTCGACGAGATCCAGACCGGGCTGGGCCGCACTGGACAGATGTTCGCTGCCGACCACTTCGGTGTGCAGCCACACATGATGACCCTCGCCAAGGGACTCACCGGCAGTGGCCTTCCGATGGCCGCCATCCTCACCGAAGAACGTATGGCCGACTGGGACCGTAGCCTGCACAGTTTCACCTATGGCAGCCACACCCTGTCGGCCGCGGCCGCCCTGGCCACGCTGGAGATCGTCCAGCGACCCGGCTTCCTGGAGAACGTACGAGCCAGCGGCGATGTGCTCCTCGGCCGGCTGCGAGACCTCCAGAAGGACAACCCCGTGATCGGCGACGTCCGAGGGGTCGGGCTGATGCTCGGGGTGGAACTGGTGGAGCCCGACGGTTCCAAGGCCGTCGCCCGCGCCCACGCCTACCAGCGGTCGCTCCAGGACCATGGCATCCTCACGCGCGTCTCCGAGCACGGAGAGGGCAGCACGATCGAGCTACGCCCCCCTCTCATCCTGACGCCCGCAGACGCCCACATGGTCGCCGACCGCTTCGGCGAGGCGCTGGAGGGCATCGCGTGA	MATTKRLPAPQDAAQYQLGDITLVRGEGIRAWDAEGREFLDCVSGTFNLLLGHNHPEVMAAVREQTERLVFASSSFQTEPTNRVIQELAAISPPNLTRVNLRSSGGSTANEGAIKMAQLHTGRRDVIVPFRAHLGQSLATASLNGTTKMRAPFPHRYPGGLHVPGPYCFRCFYRQTPETCGMLCVDRIEDFITYASSGSVACVVIEPISGAGGNIVPPAGYLQELRRFCDEREIVLIFDEIQTGLGRTGQMFAADHFGVQPHMMTLAKGLTGSGLPMAAILTEERMADWDRSLHSFTYGSHTLSAAAALATLEIVQRPGFLENVRASGDVLLGRLRDLQKDNPVIGDVRGVGLMLGVELVEPDGSKAVARAHAYQRSLQDHGILTRVSEHGEGSTIELRPPLILTPADAHMVADRFGEALEGIA	MSKFFIDRPIFAWVIALVIMLAGGLSILSLPVNQYPAIAPPAIAVQVSYPGASAETVQDTVVQVIEQQMNGIDNLRYISSESNSDGSMTTTVTFEQGTDPDIAQVQVQNKLQLATPLLPQEVQRQGIRVTKAVKNFLMVVGVVSTDGSMTKEDLSNYIVSNIQDPLSRTKGVGDFQVFGSQYSMRIWLDPAKLNSYQLTPGDVSSAIQAQNVQISSGQLGGLPAVKGQQLNATIIGKTRLQTAEQFENILLKVNPDGSQVRLKDVADVGLGGQDYSINAQFNGSPASGIAIKLATGANALDTAKAIRQTIANLEPFMPQGMKVVYPYDTTPVVSASIHEVVKTLGEAILLVFLVMYLFLQNFRATLIPTIAVPVVLLGTFGVLAAFGFSINTLTMFGMVLAIGLLVDDAIVVVENVERVMAEEGLSPREAARKSMGQIQGALVGIAMVLSAVFLPMAFFGGSTGVIYRQFSITIVSAMALSVIVALILTPALCATMLKPIEKGDHGEHKGGFFGWFNRMFLSTTHGYERGVASILKHRAPYLLIYVVIVAGMIWMFTRIPTAFLPDEDQGVLFAQVQTPPGSSAERTQVVVDSMREYLLEKESSSVSSVFTVTGFNFAGRGQSSGMAFIMLKPWEERPGGENSVFELAKRAQMHFFSFKDAMVFAFAPPSVLELGNATGFDLFLQDQAGVGHEVLLQARNKFLMLAAQNPALQRVRPNGMSDEPQYKLEIDDEKASALGVSLADINSTVSIAWGSSYVNDFIDRGRVKRVYLQGRPDARMNPDDLSKWYVRNDKGEMVPFNAFATGKWEYGSPKLERYNGVPAMEILGEPAPGLSSGDAMAAVEEIVKQLPKGVGYSWTGLSYEERLSGSQAPALYALSLLVVFLCLAALYESWSIPFSVMLVVPLGVIGALLATSMRGLSNDVFFQVGLLTTIGLSAKNAILIVEFAKELHEQGKGIVEAAIEACRMRLRPIVMTSLAFILGVVPLAISTGAGSGSQHAIGTGVIGGMVTATVLAIFWVPLFYVAVSTLFKDEASKQQASVEKGQ	40.54	gnl|BL_ORD_ID|1832|hsp_num:0	1925		
BGC0000723.1|Validamycin_17 # 17053 # 18054 # 1 # ID=1_17;partial=00;start_type=GTG;rbs_motif=AGG;rbs_spacer=7bp;gc_cont=0.708	BGC0000723.1|Validamycin_17 	17053	18054	+	Loose	700	33.4982	Tet(X4)	33.33	3004720	protein homolog model	n/a	n/a	glycylcycline; tetracycline antibiotic	antibiotic inactivation	tetracycline inactivation enzyme	GTGAGAGTGACTCTGGAGGAGGGCGGGCCTCGTCTGCACCGCTCGCCGCCGCCGCGCCCGCGTGAAGATCCCGCCGTACTCGTCGGCATCGAACTGGCCGCGCTGTGCCGCTCCGACCTCAAGGAGGTAGCCGGCACCCGTCACGGCCCCAGCCAGTTCGGGCACGAACTCGTCGGTGTCGTCCGCGAGTCCACCACCTCTGCGTTCGCCGAAGGCACTCGCGTCGTCCTGGACCCGAACGTGAAGGTGGAGCGGGGCACCGGGTTCGCCGATCACATGTGGGCGGCGGGCCCGGACGACCTGCTGCGGCACGCCCTGCAACCGGTACCGCACGGCCCGGCCGCCCGTCGCCTGGTCTTCGCCGAGCCGATCGCCTGCGCCCAGCACTGTCTGAGCGCCATCAAGAGGCAGGTCGGCAGCCTGCGGGGTGCACAAGTCGTGGTGCTCGGTGCCGGGACCGCCGGGCTCTTCATCGCGGCGCTCGCCGAGCGTGCGGGCGCCCAGGTGTCGGTCTGCAATCGGAGCCGCGCTCGGATGGACGCGGCCCGCAAGGCGGACCTGCTCGATGTACCCACACTGCTCTTCGGTGAACTGGCCGGAGACAGGGCCGACGTGGTGGTGGTCGCCACCAGCTTCGTGACGCCCACCGTGCTGGACGAGGCGCTACGCCTGGTCGCGCCAGGTGGTCTGGTGCTGCTCTACGGTGGCACCGCACCAGGTGACCGGCACCCCGGGCTGGAATGTGACCTCGATCAAGTGCGGCGCACCGAGACCGTCGCCGCCTGCACCTGGCAGGGCCACTCACTCCATGTGGCCGGCAGCTACGGCACGACCGCGGAGGATTTCGCCGCCGCGATCGGTGACCTCACTGACGCGGCGTCACCTCTGCGCGCCGAAGCCCTGGTGGCCGCTGAAGTGGACCTGCCAGGCTTGCTCGGACTGCTGCGGACCCCGGACGCCCTGGGACCCGGCAAGATCATTGTCCACCCCGAACCCTCCTGA	MRVTLEEGGPRLHRSPPPRPREDPAVLVGIELAALCRSDLKEVAGTRHGPSQFGHELVGVVRESTTSAFAEGTRVVLDPNVKVERGTGFADHMWAAGPDDLLRHALQPVPHGPAARRLVFAEPIACAQHCLSAIKRQVGSLRGAQVVVLGAGTAGLFIAALAERAGAQVSVCNRSRARMDAARKADLLDVPTLLFGELAGDRADVVVVATSFVTPTVLDEALRLVAPGGLVLLYGGTAPGDRHPGLECDLDQVRRTETVAACTWQGHSLHVAGSYGTTAEDFAAAIGDLTDAASPLRAEALVAAEVDLPGLLGLLRTPDALGPGKIIVHPEPS	MSNKEKQMNLLSDKNVAIIGGGPVGLTMAKLLQQNGIDVSVYERDNDREARIFGGTLDLHKGSGQEAMKKAGLLQTYYDLALPMGVNIADEKGNILSTKNVKPENRFDNPEINRNDLRAILLNSLENDTVIWDRKLVMLEPGKKKWTLTFENKPSETADLVIIANGGMSKVRKFVTDTEVEETGTFNIQADIHHPEVNCPGFFQLCNGNRLMAAHQGNLLFANPNNNGALHFGISFKTPDEWKNQTQVDFQNRNSVVDFLLKEFSDWDERYKELIRVTSSFVGLATRIFPLGKSWKSKRPLPITMIGDAAHLMPPFAGQGVNSGLMDALILSDNLTNGKFNSIEEAIENYEQQMFIYGKEAQEESTQNEIEMFKPDFTFQQLLNV	86.49	gnl|BL_ORD_ID|2319|hsp_num:0	3402		
BGC0000723.1|Validamycin_19 # 18417 # 18845 # -1 # ID=1_19;partial=00;start_type=ATG;rbs_motif=AAGG;rbs_spacer=6bp;gc_cont=0.618	BGC0000723.1|Validamycin_19 	18417	18845	-	Loose	800	26.1794	MuxA	43.75	3004073	protein homolog model	n/a	n/a	macrolide antibiotic; monobactam; tetracycline antibiotic; aminocoumarin antibiotic	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGCGGCCAGCGCACCTCAGTCAAATCCTTGAGGAGTACATCCGCTTCCGCGAGGGCCTCGGCGTCATGTGTTGTCGTCAGGCCGACACAGAAAATTCCCGCACGTTTAGCCGCGAGGATGCCGGCTGGCGCGTCCTCGAACACTATTGCCTGACTCGGCTCGACGTTCAATGCCGAACAGGCGGTACTGTAGCCTTCCGGGTCCGGTTTCCCTCGGGAGACGTCGTCAGCCGTAATCAGCACATCCAGGAGTTGCAGCGCCCCGAGGGTCGTAAGCGCACTCTCGGCGTAGTCGCGTGGGCCCGAAGTAACCACTCCGAGAGGCACCCTCATTTGCTGCAACTGGTGCAGCAGTTCCATTGCGCCGTCAACCGTGACGGCGGCTGGCATATCAGGGAGCGCGGCGTATGCCGCCACCTCGGCACATAA	MRPAHLSQILEEYIRFREGLGVMCCRQADTENSRTFSREDAGWRVLEHYCLTRLDVQCRTGGTVAFRVRFPSGDVVSRNQHIQELQRPEGRKRTLGVVAWARSNHSERHPHLLQLVQQFHCAVNRDGGWHIRERGVCRHLGT	MTPTTGKSKFRTLRPWLITALAFAAVIGLVMWLAAPASAPSSDGRPGRGGKPGAALPKANALTVGVARVEQGDLALHFNALGTVTAFNTVNVKPRVNGELVKVLFQEGQEVKAGDLLAVVDPRTYKAALAQAEGTLMQNQAQLKNAEIDLQRYKGLYAEDSIAKQTLDTQEAQVRQLQGTIRTNQGQVDDARLNLTFTEVRAPISGRLGLRQVDIGNLVTSGDTTPLVVITQVKPISVVFSLPQQQIGTVVEQMNGPGKLTVTALDRNQDKVLAEGTLTTLDNQIDTTTGTVKLKARFENADGKLFPNQFVNVRLLAQTLKGVLTIPANAVQRGTNGIYVYVVGADNKVSQRSVAIGTSENERVVVESGLKAGEQVVVEGTDRLRDGMEVRVAEASPQVLEGEPQKPQTGRPSGLQGDSVGSGSAE	33.33	gnl|BL_ORD_ID|2349|hsp_num:0	2717		
BGC0000723.1|Validamycin_20 # 19683 # 21722 # -1 # ID=1_20;partial=00;start_type=GTG;rbs_motif=AAG;rbs_spacer=8bp;gc_cont=0.679	BGC0000723.1|Validamycin_20 	19683	21722	-	Loose	500	28.8758	mphO	39.53	3004543	protein homolog model	n/a	n/a	macrolide antibiotic	antibiotic inactivation	macrolide phosphotransferase (MPH)	GTGCCGGCCGCCCTCGCCGTCGCCATCGCGGCGGTAGGACAACCGCTCAACCTCGCCCCCATCGTGACTTGTTCGACCGGGGCAGTGCCCTGCCGCTGCCACCCTGATCGACATCTGTGGTCGCACCGCCACGCGGGCGGCCGAATCAGGAATCCCTACAGTGCGGTGGCCCGACGCCGGGTCACCTTTGAAGGATGGACATCTATGGCTAGGCCTATCGAGGACTACGCGCTCATCGGCGACTTGGAGACGGCAGCGCTGGTCGGCCGTGACGGGACGATCGACTGGTTGTGCCTGCCCAGGCTCGACTCCCAGGCTGTTTTCGCCGCGCTCCTCGGCACCGAGGACAACGGCTTCTGGAACATCGGCCCGGCGGGGGCCGACGGCCAGAGCCCGCCAGCCGACCGTCGCACCTACCGCGGCGACTCGCTGCTCCTGGAATCGGAGTGGGACACCCCGACCGGCACCCTGCGCGTAACCGACTTCATGCCGCCGCGTGAGGGCGGGGTGCCACGTCTGATCCGGATCGTCGAAGCCGCCCGTGGCACCGTGACCGCCTCGTCGACCCTGCGCCTGCGGTTCAATTACGGCAAGGTCGTCCCCTGGGTCCACAGGACCGACGACGACCGGGTCCGCGCGGTGGCGGGCCCCCACGCAGTGTGGCTGGACACCGAAGCGGAGACGCACGGTGAAGCGCTCACCACCTGCTCCCACGTCACGCTCTCCGAGGGGGAGCGCATGGCGTTCACCCTGAGCTGGCAGCCGTCGTACGTCGGCCCGCCCGACAGCCTCGACACCGATCAGGTCCTCCAGGTGCTGGAGGAGACGGAGAAGTTCTGGGCGGACTGGGCCTCCCACTGCACCTACAACGGTCCCTACCGCGACGCTGTGGTCCGCTCCCTGATCACGCTGAAGGCCCTGACGAACCCTCTGACCGGAGGGATCGCCGCCGCAGCCACCACCTCTCTGCCCGAGGAGATCGGTGGCATACGCAACTGGGATTACCGCTACGTCTGGCTCAGGGACGCCGCGATCACCATGTCGTGCCTCCTGCGGGCGGGCTACCGCGATGAAGCCCGCGCCTGGCGGGACTGGCTCCTGCGCGCGGTCGCCGGCGACCCCGAGAACCTCCAGATCATGTACGGGATCGCCGGGGAACGGGAGATGCCCGAGATCACGCTGCCCTGGCTGACCGGCTACGAGAACTCGACCCCGGTACGCATCGGCAACGGCGCCGCAGGCCAGCGCCAACTCGATGTGTACGGTGAAGTGATCGAGGCCCTGCTCCTGGCGGCGCACCTCGGCCTGGAACGCGACGAGACCAGCAACACGCTGCTGATCAAACTCGTCCAGTTCGTCGAAGCTCACTGGCATGAGCCCGACAAGGGTATCTGGGAATCCCGCGGCCCCGACCGGCACTTCGTGCACTCCAAGGTCATGGCCTGGGTAGCGGTCGACTGCGCTATCAAGCTGGTCGAAGGCGGCCACGCGGACGGCCCCGTGGATCACTGGAGGACCCTGCGTGACGCGATCCACCGGGACGTGTGTGACAACGGGTACGACCCCGGCCGCAACACCTTCACCCAGTACTACGGCAGCCAGGAGCTGGACGCCGCTCTGCTGCTGATACCCCAGGTCGGTTTCCTCCCGGCCGACGACGAGCGGGTCATCGGCACCATCGAGGCGGTTCAACGGGAGCTCTCCACCCCCGACGGGTTTCTGCTGCGCTACCCGACCGAGGGGAACAACGCCGGCGGCGACGGCCTGACCGGAGATGAGGGTGCGTTCCTCGTCTGCGCGTTCTGGCTGGCCGACGACCTGGCGATGATCGGCCGTGTCGCTGAGTCGCGTGACCTGTTCGAGCGTCTGCTCGCCCTACGCAACGACGTCGGTCTGCTGGCCGAAGAGTGGGACCCGCACCAGCAGCGACAGGTCGGTAACTACCCGCAGGCCTACTCCCACATCGGCATCGTTGATGCCGCGCTCTCTCTGGAGAGCCCGGTTCAGCGACGTCCGCTCGCCCTCAGGATCACGCCGTGA	MPAALAVAIAAVGQPLNLAPIVTCSTGAVPCRCHPDRHLWSHRHAGGRIRNPYSAVARRRVTFEGWTSMARPIEDYALIGDLETAALVGRDGTIDWLCLPRLDSQAVFAALLGTEDNGFWNIGPAGADGQSPPADRRTYRGDSLLLESEWDTPTGTLRVTDFMPPREGGVPRLIRIVEAARGTVTASSTLRLRFNYGKVVPWVHRTDDDRVRAVAGPHAVWLDTEAETHGEALTTCSHVTLSEGERMAFTLSWQPSYVGPPDSLDTDQVLQVLEETEKFWADWASHCTYNGPYRDAVVRSLITLKALTNPLTGGIAAAATTSLPEEIGGIRNWDYRYVWLRDAAITMSCLLRAGYRDEARAWRDWLLRAVAGDPENLQIMYGIAGEREMPEITLPWLTGYENSTPVRIGNGAAGQRQLDVYGEVIEALLLAAHLGLERDETSNTLLIKLVQFVEAHWHEPDKGIWESRGPDRHFVHSKVMAWVAVDCAIKLVEGGHADGPVDHWRTLRDAIHRDVCDNGYDPGRNTFTQYYGSQELDAALLLIPQVGFLPADDERVIGTIEAVQRELSTPDGFLLRYPTEGNNAGGDGLTGDEGAFLVCAFWLADDLAMIGRVAESRDLFERLLALRNDVGLLAEEWDPHQQRQVGNYPQAYSHIGIVDAALSLESPVQRRPLALRITP	MTETSPSSPSSATADAGTPPPADLEQLLALAADHGLDLLGDSLRTEEIGLDFRVAFARSRDWQDWVLRIPRRAEVLARAAVEGRLLAHLAPHLDIAIPDWRISTERLIAYPLLPGTPGLTVSADGTVEWHVDMASTEYARALGTFLAQLHTVDPEEAAATGIPSRTPSEVRGVWREDLTRVAEAFPIAPALRERWEAWLAEDSYWPDRSVLTHGEVYPGHTLVEGERLSAVLDWTTASVGDPARDLMFHRSSAPPEAFAATLAAYVAGGGTLHPRLGEHAEEMFSASPLAYGLYALETGEEEHRAAAAAALDPPDAD	214.20	gnl|BL_ORD_ID|2754|hsp_num:0	3219		
BGC0000723.1|Validamycin_21 # 21910 # 22224 # 1 # ID=1_21;partial=00;start_type=GTG;rbs_motif=AAGG;rbs_spacer=7bp;gc_cont=0.724	BGC0000723.1|Validamycin_21 	21910	22224	+	Loose	700	23.483	cmlv	47.92	3002700	protein homolog model	n/a	n/a	phenicol antibiotic	antibiotic inactivation	chloramphenicol phosphotransferase	GTGCGCCGCCCGCGACATCCGTTCCGCCGCCGGGGATCTGCGGCGGCCCGCGGTGAGAGGTGCGGGAACAGCAACCCTCCCGGGGAGACCCGAGGGGCCAGCCACGTCGGCGGGACCTCGCTGACTGTGCTGGAGGTGGCCGGGTCCTCCAGCGCGGCCCGCGCCCTGCGCGCAGCGCGGCAGAGCCCAGGCGTCGTGTTCGTCGAACGGAACCGCGGCGCCCAGAAACCGCCGCACCCCGCACGTAGGGTACGGATCGTCAAGAACCAGGTCATTGTGCAGCCCGATAGGGCAGCTGGGCAATGTGGCCGGTAA	MRRPRHPFRRRGSAAARGERCGNSNPPGETRGASHVGGTSLTVLEVAGSSSAARALRAARQSPGVVFVERNRGAQKPPHPARRVRIVKNQVIVQPDRAAGQCGR	MPSPSAEPTTSTPTPDAGPAASPRMPLAVYILGLSAFALGTSEFMLSGLVPPIAEDMNVSIPRAGLLISAFAIGMVVGAPLLAVATLRLPRKTTLIALITVFGLRQMAGALAPNYAVLFASRVISALPCAGFWAVGAAVAIAMVPVGSRARALAVMIGGLSIANVLRVPAGAFLGEHLGWASAFWAVGLASAIALVGVVTRIPRIPLPETRPRPLKNEVAIYRDRQVLLSIAVTALAAGGVFCAFSYLAPLLTDVSGLDEAWVSGVLGLFGIGAVVGTTIGGRVADAHLFGVLLTGISASTVFLVALALFASNPAATIVLTFLLGVSAFYTAPALNARMFNVAGAAPTLAGATTTAAFNLGNTGGPWLGGTVIDANLGFASTAWAGAAMTVLGLGTAALALRLTKRPAPGHVVARSRGAGGTTPSEPARGKATSSC	23.85	gnl|BL_ORD_ID|662|hsp_num:0	703		
BGC0000723.1|Validamycin_22 # 22212 # 22553 # 1 # ID=1_22;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=11bp;gc_cont=0.675	BGC0000723.1|Validamycin_22 	22212	22553	+	Loose	300	25.0238	vanXYG	42.11	3003069	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanXY	ATGTGGCCGGTAAGGGCATGGGGCTTCTTCTGTTCAGAGATGGTGGGGCAGAGGTGGTGGTCGATCAGCGCGATGAACGCGCCGTGCCGGCATGCGCTTCGCTTCCCGGGCGCCGACCCGCGTCAGGTCGTTCCCGGGGCGGGTTACAGAGCCATGCGTGGGTGGCCGGCACTGTATGAGGGTGTCCGGCCACAGGCGTTGACCGCGATGAGGGACGGAGACCGGCGGGGCCCGAAGAAGTCGGACACTGGCGAAGTGGGGGCAGCCAGGTTGCTGGTGTCGACCCCGATGATGGTACCGATCGCCCGCGTGCCGTGCGCCCCCCATGCATCAGTGACCTGA	MWPVRAWGFFCSEMVGQRWWSISAMNAPCRHALRFPGADPRQVVPGAGYRAMRGWPALYEGVRPQALTAMRDGDRRGPKKSDTGEVGAARLLVSTPMMVPIARVPCAPHASVT	MMKTIELEKEEIYCGNLLLVNKNYPLRDNNVKGLVPADIRFPNILMKRDVANVLQLIFEKISAGNSIVPVSGYRSLEEQTAIYDGSLKDNGEDFTRKYVALPNHSEHQTGLAIDLGLNKKDIDFIRPDFPYDGICDEFRRAAPDYGFTQRYARDKEEITGISHEPWHFRYVGYPHSKIMQENGFSLEEYTQFIKAYLEDNKYLFEQAHRAEIEIYYVPAKDDKTLIKIPENCVYQISGNNIDGFVVTIWRKTDD	44.49	gnl|BL_ORD_ID|235|hsp_num:0	253		
BGC0000723.1|Validamycin_23 # 22632 # 23828 # -1 # ID=1_23;partial=00;start_type=ATG;rbs_motif=AAGG;rbs_spacer=13bp;gc_cont=0.696	BGC0000723.1|Validamycin_23 	22632	23828	-	Loose	700	32.7278	Staphylococcus aureus norA	28.43	3004667	protein homolog model	n/a	n/a	fluoroquinolone antibiotic	antibiotic efflux	major facilitator superfamily (MFS) antibiotic efflux pump	ATGACCGATCGCGTGTCGCTTCGATCGCGTCGTCGGGTATCCGTCGTCTTCGCCGGACACGGCGCGGTCGTGGGGGCGTTCGCCACTCGAATCCCCTGGCTACAGCAGCACCTCGGCCTCAGCGACAGCACTCTTGGTGTGGCGCTCCTTGCCCCGGCTCTCGGCTCGTTCGTGGCGATGCCCTTCACCAGCCGCCTGGTCCATCGCTTGGGCAACTCCCGTGCACTGAGGTGCCTGTTTCCGCTGTGGTGTGGCTCGCTCGTCCTGCCGGCGCTTGCGCCGAACCTGCCCGCCCTGTGCCTGGCTCTGGGGATATTCGGCGCGACCTCGGGTATGACGGATGTCCTGATGAACGCGCAGGGGGTGCTGGTCGAGCAGCGTCTGCGGCGCCCCGTCATTCCCAGTCTGCACGGCATGTGGGCCGTAGGAGGGCTGGTCTCCTCGGGCTGCGGTGCGCTCGCCGCCGGCGCCGGCATCGATGCCCGCTTGCATTTCGCTGTGACCTCCGCGGTCCTGGCGGGCATCGGGCTACTGGCCACCAGGCATCTGCTGGACGCGGATCCGACGGAGGCCCGACAGCCACCGCCTCGTTTCGCGCTTCCCCCGCTGTCCACCCTCCCCCTCGGCATTCTCGGCTTCTGCGCCGTGTTCGCCGAGGGGGCCAGCGGAAACTGGAGCGCGGTGTACCTGACCTCGACCGCGAAGGCGCCCGAGGGAATCGCCGCACTCAGTTACACCGGGCTCAGCTTCACGCTGGCGCTGGCCAGACTCGCCAGCGGCTTCGTCGTCACACGCCTGGGACCGGTCCGTACGGTGCGACTGGGCGGCGGAATCGCGGCGTTAGGCGGCACGCTGGTCGTGTTGGGCCGCACCCCACCAGTCGTCATCGCCGGATTCGCGCTGATCGGCACCGGCGTCGCCGCTGTGCTGCCCCTCACCTTCAGCGCTGCCGGTGGGCATGGGGGCGACCCGAGCCGGAACATCGCCGGCGTCGCCACCATCACCTACACCTCGAACCTTCTTGCCCCGGCTGTGACGGGCGCCGTCGCTGATGCCACCTCCTTGCCGGCGGCCTTCGCACTGGTGACCGCGTTCGCGACGTGCCCGCTGTTCCTCGCGAGCACGCTCGCGAAACCTGCCCAGTCGCCCGGTGGGGAGAGACAGAGCGCGCCACAGCGCGCAGACCTCTCCTCCTGA	MTDRVSLRSRRRVSVVFAGHGAVVGAFATRIPWLQQHLGLSDSTLGVALLAPALGSFVAMPFTSRLVHRLGNSRALRCLFPLWCGSLVLPALAPNLPALCLALGIFGATSGMTDVLMNAQGVLVEQRLRRPVIPSLHGMWAVGGLVSSGCGALAAGAGIDARLHFAVTSAVLAGIGLLATRHLLDADPTEARQPPPRFALPPLSTLPLGILGFCAVFAEGASGNWSAVYLTSTAKAPEGIAALSYTGLSFTLALARLASGFVVTRLGPVRTVRLGGGIAALGGTLVVLGRTPPVVIAGFALIGTGVAAVLPLTFSAAGGHGGDPSRNIAGVATITYTSNLLAPAVTGAVADATSLPAAFALVTAFATCPLFLASTLAKPAQSPGGERQSAPQRADLSS	MNKQIFVLYFNIFLIFLGIGLVIPVLPVYLKDLGLTGSDLGLLVAAFALSQMIISPFGGTLADKLGKKLIICIGLILFSVSEFMFAVGHNFSVLMLSRVIGGMSAGMVMPGVTGLIADISPSHQKAKNFGYMSAIINSGFILGPGIGGFMAEVSHRMPFYFAGALGILAFIMSIVLIHDPKKSTTSGFQKLEPQLLTKINWKVFITPVILTLVLSFGLSAFETLYSLYTADKVNYSPKDISIAITGGGIFGALFQIYFFDKFMKYFSELTFIAWSLLYSVVVLILLVFANGYWSIMLISFVVFIGFDMIRPAITNYFSNIAGERQGFAGGLNSTFTSMGNFIGPLIAGALFDVHIEAPIYMAIGVSLAGVVIVLIEKQHRAKLKEQNM	102.58	gnl|BL_ORD_ID|2263|hsp_num:0	3367		
BGC0000723.1|Validamycin_24 # 23961 # 25229 # -1 # ID=1_24;partial=00;start_type=ATG;rbs_motif=AAGG;rbs_spacer=8bp;gc_cont=0.676	BGC0000723.1|Validamycin_24 	23961	25229	-	Loose	550	32.7278	PmrF	36.54	3003578	protein homolog model	n/a	n/a	peptide antibiotic	antibiotic target alteration	pmr phosphoethanolamine transferase	ATGCCCGGTGCGACATCCCATGTGCCACTGCTCTCGGTCGTCATCCCGACATACAACCGAGACGCCCTCCTCGACCGGACGTTAGGCACGCTGGCCCGTCAGACGACGGCACCCGAGGACTTCGAGGTCGTGGTGTCCGACGATGGCTCGACAGACACCACCCGCGACGTCGTGCGGTCCTACGAGGACCGGCTGCGCATCAAGTACGTCTTCCAGGAAGACCTCGGATACCGAGTCGCCAGCGCGCGCAACGGTGGGGCACGCCTGGCCTCCGCACCCCTCCTGGCCTTCCTCGACACCGGTGTCCTGGCGGGGCCGCAGTACGTCCAGTCGGTCCTCGCCGCCCACGCCGGGCCGGCGCCCGCCAAGGTGGTCCTCGGCTGCTGCTACGGCTACGATCCGCGCAATCCCCACCCCGAACTCCACTCCCTCGTCGAGGAGTTCCCCCCGGAGGAGGCCGTGAGAAGGGTCGGGGACGCCCCCTGGTTCCAGGACATGCGGCTTCCGGAGTTCACCGCGGTCGACTTCGACCTAAGCCGTATGCACATGCCCTGGCTGTGGTTCTGGACGCTCAACGTGTCGCTGCCGGCAGCCGACTTCTGGCGGGTCGGCGGGTTCGACGAGGACTTCACCGGCTGGGGCGGGGAGGACATCGAACTCGGCTACCGGCTGCACGCACACGGCATCCCCATGACGGTCTCGCGTGAGAGCTGGGGGATCGAAGCGCCGCACGAGCGCACTCATGAGGCGAACGTCTCCTCCCTCATGCTCAATTGCGACCGGTTCGTCCGCAAGCACCCCTCCCTGCTCCCCGAGCTGTTCTGGGCCGTGACCAACAGGGGCATCTTCGGCTCCGTCGAGACTGAGCGGCTTCGCTTCGAGGAATGGGCAAGCCAGGCCCGCGGGCAACAGGTCCTGGACGAGATCGCCATCGGGTTGGACACCCTGCCCCCGTCGCAGCACACCCAGCGGGTGGCGGTGTTCGGAAGCGGCACGGAGGGGCTTCCCACCGCTCCGCGGCAGAATGTCGAACTCTTCCTGTGTGATTACGATGAGGGGGTGCTCGCACGGCAAGAGAGCCGCGACGATGGCGCCGTCTCGACCTGGCATCTGTCCGGGCTGCGTACCCCCTGGCCCGACCAGCACTTCGACCTGGTCATCATCACCTCGCGCATGGACGGGCCCCGGCAGGCATGGGGCGAGGCGTTCACCAAGGAGGCGCACCGGATCGCGAGCTCAGTCGTCGAGCCGTCTCTTAGCGGTGACTGA	MPGATSHVPLLSVVIPTYNRDALLDRTLGTLARQTTAPEDFEVVVSDDGSTDTTRDVVRSYEDRLRIKYVFQEDLGYRVASARNGGARLASAPLLAFLDTGVLAGPQYVQSVLAAHAGPAPAKVVLGCCYGYDPRNPHPELHSLVEEFPPEEAVRRVGDAPWFQDMRLPEFTAVDFDLSRMHMPWLWFWTLNVSLPAADFWRVGGFDEDFTGWGGEDIELGYRLHAHGIPMTVSRESWGIEAPHERTHEANVSSLMLNCDRFVRKHPSLLPELFWAVTNRGIFGSVETERLRFEEWASQARGQQVLDEIAIGLDTLPPSQHTQRVAVFGSGTEGLPTAPRQNVELFLCDYDEGVLARQESRDDGAVSTWHLSGLRTPWPDQHFDLVIITSRMDGPRQAWGEAFTKEAHRIASSVVEPSLSGD	MFEIHPVKKVSVVIPVYNEQESLPELIRRTTTACESLGKEYEILLIDDGSSDNSAHMLVEASQAENSHIVSILLNRNYGQHSAIMAGFSHVTGDLIITLDADLQNPPEEIPRLVAKADEGYDVVGTVRQNRQDSWFRKTASKMINRLIQRTTGKAMGDYGCMLRAYRRHIVDAMLHCHERSTFIPILANIFARRAIEIPVHHAEREFGESKYSFMRLINLMYDLVTCLTTTPLRMLSLLGSIIAIGGFSIAVLLVILRLTFGPQWAAEGVFMLFAVLFTFIGAQFIGMGLLGEYIGRIYTDVRARPRYFVQQVIRPSSKENE	131.06	gnl|BL_ORD_ID|1977|hsp_num:0	2014		
BGC0000723.1|Validamycin_25 # 25271 # 25426 # -1 # ID=1_25;partial=00;start_type=ATG;rbs_motif=AAGG;rbs_spacer=8bp;gc_cont=0.628	BGC0000723.1|Validamycin_25 	25271	25426	-	Loose	500	21.1718	aad(6)	43.75	3002628	protein homolog model	n/a	n/a	aminoglycoside antibiotic	antibiotic inactivation	ANT(6)	ATGCTTCAGGTATCCGGGATCGAGGGTAGACTCAGCGCGAGCGGAACGGGTCCCGCGACCAGAGCCGATCTGGTGGTGAGCCACCTCGTCGTCCGACATCTTCGGTGGAAGGTGTCGATATACCCGGCCGCCCCTCCCCCTGGCGTGTATGCGTAA	MLQVSGIEGRLSASGTGPATRADLVVSHLVVRHLRWKVSIYPAAPPPGVYA	EGSRANINIPKDEFQDYDITYFVSDIEPFISNDDWLNQFGNIIMMQKPEDMELFPPEEKGFSYLMLFDDYNKIDLTLLPLEELDNYLKGDKLIKVLIDKDCRIKRDIVPTDIDYHVRKPSAREYDDCCNEFWNVTPYVIKGLCRKEILFAIDHFNQIVRHELLRMISWKVGIETGFKLSVGKNYKFIERYISEDLWEKLLSTYRMDSYENIWEALFLCHQLFRAVSGEVAERLHYAYPEYDRNITKYTRDMYKKYTGKTGCLDSTYAADIEERREQ	18.48	gnl|BL_ORD_ID|1469|hsp_num:0	1562		
BGC0000723.1|Validamycin_26 # 25682 # 26209 # -1 # ID=1_26;partial=00;start_type=GTG;rbs_motif=AAGG;rbs_spacer=5bp;gc_cont=0.669	BGC0000723.1|Validamycin_26 	25682	26209	-	Loose	1250	25.0238	mecA	39.13	3000617	protein homolog model	n/a	n/a	penam	antibiotic target replacement	methicillin resistant PBP2	GTGGGCGCGATGTTCACAATCCGCAGCTACGCCTCGTGCCCTCTGGACGGCGTGGACTGGAGCCCGTTCGACATCGTCGGCCTGGACGCCTTCCGGAGTCTGCGCAGCGCCGCCCCACACCGCAACGACCTGCGCAAGGAGTTCACCCACGGCAAGCCGGTGGCCATCATGGAAGTCGGCTGCTGCACCTTCCGCGGGGCGGGCGACTACGGCGGCTCGGGCTGGTACACGGCCATGGAGCCGGACGGTGTCACCCCCAAGCCGCACCTGGTGCGTGACGAGAGCGAACAGGTCCGCTACCTCGACGAGCTCATAACCGTCTTCGGAGACGAAGGTGTCGACTGTCTTCTGGGTGGTTCGGCCTCGCCGGCTACGGCACTGCCCACCGTCTGTCCGGACCGTCCGACCGGCCTGGGGTTCCTGGTGGTCTTCTGGTGTCCGCCGAGCCATGGCCTGGGCTACGCACACACCTTCGTTCGCCGGACTCTCGTTCACACAATCGTCACAGACCGAACCCTCCTGCCCTGA	MGAMFTIRSYASCPLDGVDWSPFDIVGLDAFRSLRSAAPHRNDLRKEFTHGKPVAIMEVGCCTFRGAGDYGGSGWYTAMEPDGVTPKPHLVRDESEQVRYLDELITVFGDEGVDCLLGGSASPATALPTVCPDRPTGLGFLVVFWCPPSHGLGYAHTFVRRTLVHTIVTDRTLLP	MKKIKIVPLILIVVVVGFGIYFYASKDKEINNTIDAIEDKNFKQVYKDSSYISKSDNGEVEMTERPIKIYNSLGVKDINIQDRKIKKVSKNKKRVDAQYKIKTNYGNIDRNVQFNFVKEDGMWKLDWDHSVIIPGMQKDQSIHIENLKSERGKILDRNNVELANTGTAYEIGIVPKNVSKKDYKAIAKELSISEDYIKQQMDQNWVQDDTFVPLKTVKKMDEYLSDFAKKFHLTTNETKSRNYPLEKATSHLLGYVGPINSEELKQKEYKGYKDDAVIGKKGLEKLYDKKLQHEDGYRVTIVDDNSNTIAHTLIEKKKKDGKDIQLTIDAKVQKSIYNNMKNDYGSGTAIHPQTGELLALVSTPSYDVYPFMYGMSNEEYNKLTEDKKEPLLNKFQITTSPGSTQKILTAMIGLNNKTLDDKTSYKIDGKGWQKDKSWGGYNVTRYEVVNGNIDLKQAIESSDNIFFARVALELGSKKFEKGMKKLGVGEDIPSDYPFYNAQISNKNLDNEILLADSGYGQGEILINPVQILSIYSALENNGNINAPHLLKDTKNKVWKKNIISKENINLLTDGMQQVVNKTHKEDIYRSYANLIGKSGTAELKMKQGETGRQIGWFISYDKDNPNMMMAINVKDVQDKGMASYNAKISGKVYDELYENGNKKYDIDE	26.20	gnl|BL_ORD_ID|1245|hsp_num:0	1321		
BGC0000723.1|Validamycin_27 # 26926 # 27774 # -1 # ID=1_27;partial=00;start_type=ATG;rbs_motif=AAGG;rbs_spacer=9bp;gc_cont=0.722	BGC0000723.1|Validamycin_27 	26926	27774	-	Loose	500	27.335	OXA-89	39.29	3001625	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	ATGACGTCAGACGTCCCGTTCGAACAGCCGTCCTTCGACTTCGACCTCTTCTTCTCTGCCTACTGGCGCAAACGGCCCCTGTACGTCCCCGGCGGGGCGAAGGAGCTGCTGGGCCGCGTGTGGACCGACGACGACTTCGACGCCGCTCTGGCCGGGGCGCGCGCCGACGGCACGGAGGTCAAGGAGCGGCCCGGTGAGGTGACGTTCATCGAACAGGTCTCCCGCTTCGACACCGACCTGCACGACCGCGCGGACCGGCTCGCGGGCGTCTTCGGCGCGCCGCAGGCCTGGTTCGACGCGATCCGCACGTGCGCGCGCAGCGGCATCGGCGCCCACTTCGACCACAGCGACAACTTCGTGCTCCAGCAGAACGGCACGAAGGAGTGGACGCTCGCCTCCTCCCAGCACCTGGACCGCCAGGACGTCGTACGGCGCATGATGAACCACCCCGGTGTGGGGGCCCACGAACTGCCCGTCGACGACAGCGTCCGCTTCACCGTCGGCCCCGGCGACCTGCTCTACATCCCGCTGCTGTGGCTGCACTCCGGCGTCTCCCGCGGCGACTCGCTCAGCGTGTCCCTGGTCTGCCCCGCCGTCTCCCTCCAGGCCGCCGTCCTCCCGCTCCTCGCCCAGGTGCTGCGCGCCCGCGGCGTCGGCCACCAGCCGGTCCCGGCCCTCCACACCGGACTGTCCCCTCAGCAGCGCGCCGAAGCCACGGCCGCCCTGGCCCGCGCGACCCGCGCCTTTCTGGAGCGGATGAGCGACGACGTGCTCGCGGACGCGGTCCTCGCGCTCCAGCACCGGCGCCTGACGGAGGAGAGCGCCCGCCCGGCGACCGACACCGCCTGA	MTSDVPFEQPSFDFDLFFSAYWRKRPLYVPGGAKELLGRVWTDDDFDAALAGARADGTEVKERPGEVTFIEQVSRFDTDLHDRADRLAGVFGAPQAWFDAIRTCARSGIGAHFDHSDNFVLQQNGTKEWTLASSQHLDRQDVVRRMMNHPGVGAHELPVDDSVRFTVGPGDLLYIPLLWLHSGVSRGDSLSVSLVCPAVSLQAAVLPLLAQVLRARGVGHQPVPALHTGLSPQQRAEATAALARATRAFLERMSDDVLADAVLALQHRRLTEESARPATDTA	MNIKTLLLITSAIFISACSHYIVSANPNHSASKSDEKAEKIKNLFNEAHTTGVLVIQQGQTQQSYGNDLARASTEYVPASTFKMLNALIGLEHHKATTTEVFKWDGQKRLFPEWEKNMTLGDAMKASAIPVYQDLARRIGLELMSNEVKRVGYGNADIGTQVDNFWLVGPLKITPQQEAQFTYKLANKTLPFSQKVQDEVQSMLFIEEKNGNKIYAKSGWGWDVNPQVGWLTGWVVQPQGNIVAFSLNLEMKKGIPSSVRKEITYKSLEQLGIL	102.92	gnl|BL_ORD_ID|1331|hsp_num:0	1416		
BGC0000723.1|Validamycin_28 # 27790 # 28869 # -1 # ID=1_28;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=8bp;gc_cont=0.716	BGC0000723.1|Validamycin_28 	27790	28869	-	Loose	920	25.409	OpmD	28.79	3000809	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; tetracycline antibiotic; acridine dye	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGACCAAGGTGACGTACCGTCTGCTGGGCCGCACCGGGCTGAAGGTGTCGAACATCGCTCTCGGCGTGGCCACCTTCGGCTCGCAATGGGGGCCGCGCTGGACCATGCCGGCCGCGGAGGCGGACACGCTGCTCGGCGTCGCCCTCGACCACGGCATCAACTTCTTCGACACCGCGAACGTCTACAACCGCGGCGAGAGCGAGACCTGGCTCGGCCGGGCCCTGCGCCGCCGGTCCGCGCGGGACCAGGTGGTGATCGCCACCAAGTGCGGGTACCGCACCGACCCGAGGGACGTGAACTCCGGCGGATGCAGCCGCCGCAACGTCGTCGCGTCCGTGGAGCGGTCGCTGCGCCGCCTCGGCACCGACCACATCGACCTGCTCTACCTGCATCTGTGGGACGGCGTCACCCCGGTCGAGGAGAGCCTGGCCGCGGCAGCGGACCTGGTCTCCGCCGGGAAGATCCGCTACGTCGGGCTGAGCAACGTGCCGGGCTGGTACGCCGGTCAGGCCGAGGCCGTCGCCCGGTGGCGGGGCTGGCCCGTCCCGGCGGCGGTCCAGCTCAACTACAACGCGCTGGAGCGGACGATCGAGCACGAGTTCTTCCCGTTCACCGAGGCCACCGGCGTCGGCCTGGTCGCGTGGGGGCCGCTCGCCAACGGCCTGCTGACGGGCCGGTACCGGGTCGACCTGGAGGAGCGGCGGATCACCGGCGACGGGCGGATGACGCAGACCTTCACCACCGGCGACGTCGACCCCTTCCGCCCGGTCGTGCCCCGCGTCATCGCATGCCTGACCGACCTGGCGGCGCGGACGGGGCGTACGCCCGGACAGCTGGCCCTGGCCTGGATCCTGAGCAAGCCGCAGATCACCAGCGTTGCCGTGGGCGTCTCCTCCGGCGACCAACTCCTGCAGAACCTGGCCGCGCTGGAGATCTCGCTGCCGCCGGAGGACCTCGCCCGGATCGACGAGGCGAGCGCGCAGCCGACCCCGTACCCGTACACGTTCCTCACCGACGGCATCCAGGCACTGGTCCATGGTCCCGAACAGCTGAGGGCAGTGCGGCCCACGACTCCGTAG	MTKVTYRLLGRTGLKVSNIALGVATFGSQWGPRWTMPAAEADTLLGVALDHGINFFDTANVYNRGESETWLGRALRRRSARDQVVIATKCGYRTDPRDVNSGGCSRRNVVASVERSLRRLGTDHIDLLYLHLWDGVTPVEESLAAAADLVSAGKIRYVGLSNVPGWYAGQAEAVARWRGWPVPAAVQLNYNALERTIEHEFFPFTEATGVGLVAWGPLANGLLTGRYRVDLEERRITGDGRMTQTFTTGDVDPFRPVVPRVIACLTDLAARTGRTPGQLALAWILSKPQITSVAVGVSSGDQLLQNLAALEISLPPEDLARIDEASAQPTPYPYTFLTDGIQALVHGPEQLRAVRPTTP	MKRSYPNLSRLALALAVGTGLAACSVGPDYQRPQSPPPRVASEHLGEFSGERREAPWWSFFDDPQLVRLVDQALARNHDIREARANLRSARALFDDRWLDQLPQVTSQAGYSRSIEQQLDYDGEPRRRLAESYRAGFDAQWEIDLFGRLGRLSDAALARAEAADADLRLVRLSIAADTARAYFEIQGYQRRLDVARAQVRSWRDTLELTRSSLQLGSGLPEDVENAQANLLRSEAAIPPLTTALESARYRLDVLRGEAPGSGAPILDGGAAAPLAKNLPLGDVDRLILQRPDVVSAERQLAASTEDVGAATAELYPRLDLGGFIGFFALRSGDLGSASRAFELAPSVSWPAFRLGNVRARLRAVEAQSDAALARYQRSLLLAQEDVGNALNQLAEHQRRLVALFQSATHGANALEIANERYRAGAGSYLAVLENQRALYQIREELAQAETASFVNVIALYKALGWGSGDLAPGAGQLAAGETAGANR	73.72	gnl|BL_ORD_ID|410|hsp_num:0	442		
BGC0000723.1|Validamycin_29 # 28893 # 29645 # -1 # ID=1_29;partial=00;start_type=ATG;rbs_motif=AAGG;rbs_spacer=7bp;gc_cont=0.722	BGC0000723.1|Validamycin_29 	28893	29645	-	Loose	1900	27.7202	MexK	41.82	3003693	protein homolog model	n/a	n/a	macrolide antibiotic; tetracycline antibiotic; triclosan	antibiotic efflux	resistance-nodulation-cell division (RND) antibiotic efflux pump	ATGGCCCAGCACGCCCTCGTCACCGGAAGCAGCCACGGTCTCGGCGCCCACCTGGCCGCCCGGCTCGCCGCCGACGGCTGGAAGGTGACCGGTCTCGGACGCCGCCCCGCGTCGGAGACCCCCGCCACACCCGGCGTCGACCACCTCCAGGCCGATCTGTCCCGGCCCGAGACCCTCAAGTGGATCACGGACCGGCTCGGTGAGGCACCCGACCTCATCATCCACAACGCCGTCAGCTACCCGCCTCGCCCCGCTCACGAACTGTCCCTGGCCGAGTTGGAGGACGTCTTCCGGGTCAACACCCTCGCCCCCTACCGGCTGACCCTGGACCTGCTGGCCGCCACCCCCGACACCCGGTTCACCTCGGTCGTCGTCATCAACTCGGAGTCCATGTTCCACGCCGACCGCGACTCCGGCGCGTACGCGGCGAGCAAGGCCGCGCTACGCGTGCTCACCGGCTCGCTCGCCGACGCCTGCCGCTCCCGCAACACGGCCGTCGCCACCCTGCTGCTGGGCCCGCTGGCCGATCCGGACAAGGTGGCGCAGCTCCAGCGGGTCGCCGCCCGCCGCGGCGTCGACGAGGCCGAGATCACCCGGGTGTTCCTGCGCAAGTCCAACCCGGACCTGGTCATCGAGGAGCTGATCGACTTCGACGCGTGCTACCGCAGCGTCCAGTACCTCGCGGGCCTCGGGCGGGCGGCCAACGGCATGCTGTGCCGGCTCGACGGCGGCTCCGCCGGCTCGCTGATCTGA	MAQHALVTGSSHGLGAHLAARLAADGWKVTGLGRRPASETPATPGVDHLQADLSRPETLKWITDRLGEAPDLIIHNAVSYPPRPAHELSLAELEDVFRVNTLAPYRLTLDLLAATPDTRFTSVVVINSESMFHADRDSGAYAASKAALRVLTGSLADACRSRNTAVATLLLGPLADPDKVAQLQRVAARRGVDEAEITRVFLRKSNPDLVIEELIDFDACYRSVQYLAGLGRAANGMLCRLDGGSAGSLI	MSFNLSAWALQNRQIVLYLMILLGAVGALSYSKLGQSEDPPFTFKAMVVQTNWPGASAEEVARQVTERIEKKLMETGDYDRIVSFSRPGVSQVTFMAREDIHSSEIPELWYQIRKKISDIRATLPQSIQGPFFNDEFGTTYGNIYALTGKGFDYAVMKDYADRLQLQLQRIRNVGKVELIGLQDEKIWIDLSNTKLATLGLPLAAVQKALEEQNAVASSGFFETASDRVQLRVSGRFDSVEEIRDFPIRVGDRTFRIGDVAEVRRGFNDPPAPRMRFMGEDAIGLAVAMKPGGDILVLGKALETEFARLQQSLPAGLELRKVSDQPAAVRTGVGEFIRVLAEALVIVLLVSFFSLGLRTGLVVALSIPLVLAMTFAAMHYFGIGLHKISLGALVLALGLLVDDAIIAVEMMAVKMEQGYDRLKAASFAWTSTAFPMLTGTLITAAGFLPIATAQSGTGEYTRSLFQVVTIALVVSWFAAVVFVPYLGAKLLPDLARLHAQKHGGSADGYDPYATAFYQRFRRLVEWCVRYRKTVIVLTLAAFVGALLLFRLVPQQFFPPSARLELLLDIKLAEGASLRSTGEEVQRLEKMLQGHDGIDNYVAYVGTGSPRFYLPLDQQLPAASFAQVVVLAKDLESREALRKWLIERMNEDFPHLRSRISRLENGPPVGYPVQFRVSGEDIPQVRELARKVADKMRENPHVVNVHLDWEEPSKVVYLSIDQERARALGVSTASLSQFLQSALTGSHVSFFREDNELIEILLRGTEQERRDLSLLPSLAVPTENGRSVALSQIATLEYGFEEGIIWHRNRLPTVTVRADIYDDSLPATLVAQIAPTLEPIRAELPDGYLLEVGGTVEDAAKGQSSVNAGVPLFIVVVLSLLMVQLRSFSRMAMVFLTAPLGLIGVTLFLLLFRQPFGFVAMLGTIALAGMIMRNSVILVDQIEQDISHGLDRWHAIIEATVRRFRPIVLTALAAVLAMIPLSRSVFFGPMAVAIMGGLIVATVLTLLFLPALYAAWFRVKKDEARA	24.39	gnl|BL_ORD_ID|2061|hsp_num:0	2206		
BGC0000723.1|Validamycin_30 # 29648 # 30292 # -1 # ID=1_30;partial=00;start_type=GTG;rbs_motif=None;rbs_spacer=None;gc_cont=0.722	BGC0000723.1|Validamycin_30 	29648	30292	-	Loose	550	30.4166	Erm(49)	28.57	3004626	protein homolog model	n/a	n/a	macrolide antibiotic; lincosamide antibiotic; streptogramin antibiotic	antibiotic target alteration	Erm 23S ribosomal RNA methyltransferase	GTGACGACGATCCCGCACGGCTACATCCGCGCCGTCCTCGGCCCCCGCGAGGAGGTGCTCGACGGCATCCTGCGGCGCTCCCTGCTCGACGACCGGCTGCCGACCATCCAGGTCGACGACAACGCGGGCCGCGTCCTGCAACTGCTCACCCTGCTGCGCCGGCCCCGGCAGGTGTTGGAGATCGGGACGCTGTTCGGCTACTCCACCATCCACCTGGCCCGCGGCCTGCCCGAGGGCGGGCGGGTGACCACGCTGGAGATCGACCCGCGGGCCGCCGAGGCCGCCCGCCGCAATCTGCGCACCGCCGGGGTCGAGGACCGGGTGGACATCGTCGTCGGCGACGCCTGCGCCTACCTGGAGACCGTGCCGGCCGGGAGCGTCGGCCTGGTCTTCATCGACGCCGACAAGAAGTCGTACCCCGACTACCTCCGGCTGTGCTACCCGCTGCTGGAACCCGGCGGCGTGCTGATCGCCGACGACGCCTTCGCCCAGGGCGACTTCACCGCCGAGCGCACCGAGGGGTCCGAGGAGGACCGCGAGGCGAAGGCCATCCACCGCTACAACCGCGCGGTCGGGCGCAGCACCCGGCTGTTCTCCGCATTCGTCGGGACCCAGAGCGGTCTCCTGGTGAGCGTCAAGGAATAG	MTTIPHGYIRAVLGPREEVLDGILRRSLLDDRLPTIQVDDNAGRVLQLLTLLRRPRQVLEIGTLFGYSTIHLARGLPEGGRVTTLEIDPRAAEAARRNLRTAGVEDRVDIVVGDACAYLETVPAGSVGLVFIDADKKSYPDYLRLCYPLLEPGGVLIADDAFAQGDFTAERTEGSEEDREAKAIHRYNRAVGRSTRLFSAFVGTQSGLLVSVKE	MRNIKDTQNFLHSKELVRHLIGICNIKLDDVVIEIGPGKGIITNELAHKARKVVAIEFDEELYEKLKNKFQSNNKVDIIYGDILNYTPRIPSYCVFSNIPFNITSEILNKFLSDKKNEKMFLIMQYEPFIKYAGNPYGAETLRSMLYKPFFDMDLKYRFDPSDFKPAPQARIVLASFERKQFPDVKKEEEKLYKDFLAYIYTNKGETFFAKIKTLFSSNQIKRVWGQIKIDKTTKISEVPYESILKVFKLFFLYGTDANKQLVVNSFNNMNKQNNKLQKNHRNNSKAKSWNSNRKRKPYHRNNV	70.39	gnl|BL_ORD_ID|2168|hsp_num:0	3324		
BGC0000723.1|Validamycin_31 # 30289 # 34704 # -1 # ID=1_31;partial=00;start_type=ATG;rbs_motif=None;rbs_spacer=None;gc_cont=0.713	BGC0000723.1|Validamycin_31 	30289	34704	-	Loose	850	31.9574	abeM	20.26	3000753	protein homolog model	n/a	n/a	fluoroquinolone antibiotic; acridine dye; triclosan	antibiotic efflux	multidrug and toxic compound extrusion (MATE) transporter	ATGGAGCACACCCGGTTCACCGTACGGAACTACACCGGCTACACCTCTGTCGTCTTCGGTCTGGGCGTGGTCTCGGTGGGGTTCGGCGCCCTCGACCTCATCATGGTCGCGCCGAAGGGCCTGGACCAGGCGGCGGCCGTCGGCCAGGCGGATGTGCTGATCTCGGCCATCTACGCCGTCTTCATCGGCGTCGTCGACGTCTTCAGCAGCCGGCTCGCCATGGCCGAGGGCGAGCAGCGGACCAGCCACCGCCTGCCGGTGCTTGGCACCGCCCTGCTGCTGTTGCTGATCCCCTGCCAGCTCCTCGGCATCGCCCTCGGCCTGGGCATCGAGCCGCTGATGCGGGCCACCGGGCAGAAGGCCGAACTGATCCCACTGGTCGGCGACTACGTTCAGGTCCGCACCTACGGCATCGCCCTGGTCCTCGGCTACATCGTCATCAGCGAGTCGCTGAAGATCTGCGGCCTGAAGAACCTGTCGGCCGTCAACCTGGTCTTCGGCCTCGCGGTGAACGCCCTGTTCAACTGGGTCTTCCTGGACACCGGCGGGGCCCGCCTTTTCGCCTCCCCGGCCCAGGCCGTCGCCGCGTCCACCCTGGTCGCTCAGGCGGCCATGGCCACCACCGGCGGCATCGTCCTGGTCCGTCGGCTGCGCACCCGACCGGACCGCTTCGTACGTCCCCGACGCCTGGAGGTCCTCACCGAGTTCCGCTCGATGGCCCGCACCGCACCCGGCATCGGACTGCGCCACTTCAACGACTACCTGGGCACGACCATCCCGCTGCTGTTCATCGGCACGCTTGGCGTCGTTCAGTTGGCCGCCGCCGCCGTGGCCACCAAGATCTACACCCTGTTCTGCCGGGTCCCGCAGGCCTGCTTCGCCGGGTCCTTCGTCTTCTACGGCTACGCCCTGGGCCGCGGCGCGGACGACCTCACCCGCACGGTGCGCAAGATGCGCCTGTACGCCGCCGTACCCACCGCGGTGGCGACCGCCGTCACCGCGCTGGCCGCGCCCTGGCTGGTCGACGCCTTCGCCAGCCCCGGCCTCGACCGGGACCTCGCGCGCAACCTGCTCCTCGCCTATCTGCTGTACGTCCCCGCCTACTTCTTCGAACAGATCTTCGGCGAAATGCTCACGGTCCAGCAGCGCGGCGGGCTGCTGTTCGTCTCCTCGACCGCGGTGACGTACCTGCTGACCATCCCCCTCGCCTGGTACTCGGTGTTCGCCCTGCACTCCACCTTCCTCGCCGTCGCCTGCAAGGGGCATCCCCACCGCCGTCCTCGCGTTCGTCTTCTGGCGCGCGCTGCGCCGCACCGGCCGGCCCGGTGCGGACCGAGCGGAAAGCGAGATGAGCCTTGCCCAGTAGCCTCCCGGCCGGCTCGCCCGGCCTGCCGGCCGACTCGTCTCCTCTCCCTGCCTTCCGGCACGACCCGGTCAAGTCGGTGCTGCCCGGCCGCGGTGGCGGCGCCTTCCATTGGGACCGGGAGCCCGCCGTCTGCGCACACCGGCGCCTCACCCACGACAGCGCCCACCTCGGTCAGACCGTCCCCGTCCCGGTCAGCTCCACGCCCGCCGTTGTCGCCGGCGTCGGCGTCGTGGTCGCCAGTGACGACGGGCGGCTGCGGTTCTTCGACCCCGGCCTCGGCAAGGTCTACTGGGAGCGCCGCCTGGACCGCTCGGTGTACGCCTCCCTCCGTCGTCGACCAGGCGCGCCGCCATGTCATCGTCGCCACGACCAGCGGGCTGATCACCTGCTTCGATCTGCGCGGCACCCTGGTGTGGTCGCGCAAGGCCGAGTCCCCCGTCTTCGCCACGCCCACCGTGCTGCCGGGCGCCGACCTGCTCGTGGTGGCGGCCTTCCACAGCCGCTGCCTGGGCCTCGCCCTCGGCACCGGCGAGCTCGTGTACGACCGCCCGCTGCCCCGCCCCTGGTCGGCGGCCCACGGCGGCGTCGCCGCCTACCGCGACCCCTACGCCAGCCCCGTCCCCGCCGCCGACGACACCGCTGTACTGTGCTGCGGGGAACACGTCGTCGCCCTGGCCGCGGACGGCACCGAGGTGTGGCGGCAAGAGATCGGCCACCCCGTCAAGGCGTCGCCCGCGCTGCTGCACGAGACCGGCCGGCTGGCCGTCTTGCCCGGTCGACGGGCGCTGCGTCCTCCTCGACGCCAAGACCGGCCGCCCCGAGGCGGAGGTCCGCCTCGGAGCCAAGATCACCGGCAGTCCGGCGGTCTCCGGGGACGTCCTGGCCGTCGGCACCCAGCTCGGCACGGTCGCCGGTCTGACCTCCTCGGGCGAGATGCGGTGGACCTCACCCCAGGGCGCGCCCCGCTCGTACACCTCGCTCACGGTGCTGCCCGACGGGAACTTCGTGGCGACGGCCGAACGCGGCAACATCGTGTGCCTCGCTCGCGAAGACGGCCGGTTCCTGTGGGAGAGCAGCCAGGTGCTCGGCCTGCCCGACCACGAACCGGCCCTGGACATCACCCCGATCGCGGCCGCCTCGGGCAGCATGTACGCCGCGTCGTACGGGGGCGACCTCTACCAGTTCCTGTTCCAGCCGTGCGACGAGGAGTGACCATGTCCGTAGACCCCGTTCTGGCGCCGGACCGGGAGAGCCTCACCGCCATGGAGGGGGCCCTGGAGGCGATGATGAGCCGGCTCCGGGAGATCGTGGCCGAGCCGCGGCTGACCCAGGAGACCCTGGTCGAGATCACCTCGATCTACAACAACGTCGCCTACATCTTCCTCTACCTGGAGGCCAACGACGAGTTCGTCGACTTCGAGCGCCTGCTGCCCTGGCGTGACGCCTTCCACAAGGACCCGGAGCTGGACCGGCGGATCCTGGAGAAGCTGGTGCTGTTGCGCTGCCCGGACCCGGAGGCGGAGGAGTCCCGGCTCGCCTACGTCGCCCAGCTGAGCGCCAAGCAGGAGCCCGCGGACATTGCCATCGAGGAGGAGCTCGACGCCCTGCTCACCGAGGCCAAGGGCGTCCTCGACGACGTCCGACGCGACCAGGCCCGGCTGCTGGAGCGCCTGGGCACACCCGCCGGATCGGGCACCCCGTCGGCCGTGTTCTACAAGCTCTCCAGCCAGGTCGGCAGCCCCGCCACCCGCGGCAAGCTCGCCCGGGCCTGGCAGGGCGCGCGCGACGCGCATCTGCCGCGGCTGCTCGGCCTGGTCGACGGGATGATCGAGGCGCGGCGGCGGCAGAGCGCCGCGCAGGGCCACCCCAGCGTGCTCGCGCGGACGTTCACCAAGTGCGCCGTCGAGGAGGCCGACGTGGCCGCCTTCCTGGAGCGCCACCTGGCACGGGCGTTGACCGCTCACACCGAACTGGAGGCGGAGATAAGGCAGTTGTGCCCCGATGCGGGCGACGAGCCGTTCGCCCACTTCGCGCACAGCGTCCGTACGGCGACCGGCGGGGCCAAGCCGCCGATGTTCGACCTCGACGACTGCCTCGACTACATCTTCACCGTCGCCCGGCACGTCTTCGGCCTCACCCTCACCCGGCAGGCGACCGGCGCCGCCCAGGTCGTCACCGTCGCCGTCCGCTCCGAGCACGGCGAGGTCGGCCACATCAACTTCGACCTGTGGGACACCGGGAACAAGACGATCGGGGCCAACCACACCAAGGGCATCCGCAACCGCACCGACTGGAGCGGCGTGGTGCAGCGGCCGGTCGCCTACGTCTCCTGCCGGTTCCGGCCGGGAGCCGACGGCGGGGGACGGATCACCTTCCAGAACATGCACAGCCTCTTCCACGAGTTCGGGCACGCCCTGAACCACCTGCTGATCCGCAAGCGGATCTCCAACCGGTCCGGCCTGGAGTACCTGCCCCTGGAACGGCTGGAGCACCTCAGCATGTGGTGCGAGAAGTGGGCCTACCACCCCGACCTGGCCCGGTACCTCTCCCTCACCCCGGCCGCGGAGGACGGACTGGCCCTGTGCCGCCGCATCAAGATGATCGAGTACCGGCGCACCTACCTGGAGCGCGCCGTGCTGGCCCTGCTGGACTTCGACGTCCACCGGCGCGCCGACGGCGGCCTCGCGGACTCCTTCCGGCGCCTGGACGAGCGGTTCGGCATCGGCCGCCACTGCACCCTGGGCGACTTCCCCGGCTACTTCACCTGGCCCATGTTCACCGCCAACCCCGGCGCCAACTTCGCCTATCTCTTCGGCGCCGCGGACAGCGCCCAGAAGTTCGCCCCCTTCCACCGCACACCCCTCGCGGACGTCTCGCCCGACCAGGCACCCGAACTATTCCTGCCCTGCTTCGACTTCGAGGCACCCACCACCCGGCCGGACAGCGAGGCCCTGTTCGCCTTCTACGACGCCGCCCGCCTCCACGACGGCACCGCGCCCTCGGCGCCGGCCGGGACCCGCGGCGCCCAGCACCTGGGAGCAGACGCGTGA	MEHTRFTVRNYTGYTSVVFGLGVVSVGFGALDLIMVAPKGLDQAAAVGQADVLISAIYAVFIGVVDVFSSRLAMAEGEQRTSHRLPVLGTALLLLLIPCQLLGIALGLGIEPLMRATGQKAELIPLVGDYVQVRTYGIALVLGYIVISESLKICGLKNLSAVNLVFGLAVNALFNWVFLDTGGARLFASPAQAVAASTLVAQAAMATTGGIVLVRRLRTRPDRFVRPRRLEVLTEFRSMARTAPGIGLRHFNDYLGTTIPLLFIGTLGVVQLAAAAVATKIYTLFCRVPQACFAGSFVFYGYALGRGADDLTRTVRKMRLYAAVPTAVATAVTALAAPWLVDAFASPGLDRDLARNLLLAYLLYVPAYFFEQIFGEMLTVQQRGGLLFVSSTAVTYLLTIPLAWYSVFALHSTFLAVACKGHPHRRPRVRLLARAAPHRPARCGPSGKRDEPCPVASRPARPACRPTRLLSLPSGTTRSSRCCPAAVAAPSIGTGSPPSAHTGASPTTAPTSVRPSPSRSAPRPPLSPASASWSPVTTGGCGSSTPASARSTGSAAWTARCTPPSVVDQARRHVIVATTSGLITCFDLRGTLVWSRKAESPVFATPTVLPGADLLVVAAFHSRCLGLALGTGELVYDRPLPRPWSAAHGGVAAYRDPYASPVPAADDTAVLCCGEHVVALAADGTEVWRQEIGHPVKASPALLHETGRLAVLPGRRALRPPRRQDRPPRGGGPPRSQDHRQSGGLRGRPGRRHPARHGRRSDLLGRDAVDLTPGRAPLVHLAHGAARRELRGDGRTRQHRVPRSRRRPVPVGEQPGARPARPRTGPGHHPDRGRLGQHVRRVVRGRPLPVPVPAVRRGVTMSVDPVLAPDRESLTAMEGALEAMMSRLREIVAEPRLTQETLVEITSIYNNVAYIFLYLEANDEFVDFERLLPWRDAFHKDPELDRRILEKLVLLRCPDPEAEESRLAYVAQLSAKQEPADIAIEEELDALLTEAKGVLDDVRRDQARLLERLGTPAGSGTPSAVFYKLSSQVGSPATRGKLARAWQGARDAHLPRLLGLVDGMIEARRRQSAAQGHPSVLARTFTKCAVEEADVAAFLERHLARALTAHTELEAEIRQLCPDAGDEPFAHFAHSVRTATGGAKPPMFDLDDCLDYIFTVARHVFGLTLTRQATGAAQVVTVAVRSEHGEVGHINFDLWDTGNKTIGANHTKGIRNRTDWSGVVQRPVAYVSCRFRPGADGGGRITFQNMHSLFHEFGHALNHLLIRKRISNRSGLEYLPLERLEHLSMWCEKWAYHPDLARYLSLTPAAEDGLALCRRIKMIEYRRTYLERAVLALLDFDVHRRADGGLADSFRRLDERFGIGRHCTLGDFPGYFTWPMFTANPGANFAYLFGAADSAQKFAPFHRTPLADVSPDQAPELFLPCFDFEAPTTRPDSEALFAFYDAARLHDGTAPSAPAGTRGAQHLGADA	MSNVTSFRSELKQLFHLMLPILITQFAQAGFGLIDTIMAGHLSAADLAAIAVGVGLWIPVMLLFSGIMIATTPLVAEAKGARNTEQIPVIVRQSLWVAVILGVLAMLILQLMPFFLHVFGVPESLQPKASLFLHAIGLGMPAVTMYAALRGYSEALGHPRPVTVISLLALVVLIPLNMIFMYGLGPIPALGSAGCGFATSILQWLMLITLAGYIYKASAYRNTSIFSRFDKISLTWVKRILQLGLPIGLAVFFEVSIFSTGALVLSPLGEVFIAAHQVAISVTSVLFMIPLSLAIALTIRVGTYYGEKNWASMYQVQKIGLSTAVFFALLTMSFIALGREQIVSVYTQDINVVPVAMYLLWFAMAYQLMDALQVSAAGCLRGMQDTQAPMWITLMAYWVIAFPIGLYLARYTDWGVAGVWLGLIIGLSIACVLLLSRLYLNTKRLSQT	328.35	gnl|BL_ORD_ID|1285|hsp_num:0	1368		
BGC0000723.1|Validamycin_32 # 34710 # 35993 # -1 # ID=1_32;partial=00;start_type=ATG;rbs_motif=AGG;rbs_spacer=11bp;gc_cont=0.736	BGC0000723.1|Validamycin_32 	34710	35993	-	Loose	1300	26.5646	vanTC	45.83	3002970	protein homolog model	n/a	n/a	glycopeptide antibiotic	antibiotic target alteration	glycopeptide resistance gene cluster; vanT	ATGAGCGGAGCAACCCCGGACCGGATCGCGTTCGAGACGGTCGAGGTCCAGGCCAACACCTTCCAGGAAACCCTGCTCGGGCTGGAGTACACCACCGGCCCCGGCCGGCCGGCCGACCTGTTCTCCCGGGCCTGCGTGGAGCAGTACGCCGACCTGCGGCTCGATCGCTTCGGGTACCTGCTCGCCCAGGTCTTCGAACCCAACGTCCTGCACGAGGCCGCCCTCCTCGCCGGCCTGTCCTACGACTCCCTGGCCGACCTGAGCCACCGGCCGACGGAACCGGTCGAACGGCTGGCCGCACTCGTCCGCGACGCGGCCGACCTCCCGGTGACCGCCCTGGTCAACACCGCGGCCGCGCTGATCAGCGTCTCCCGCTTCGACCCCGCCGAACGCCTGCTCGCCGACGCCTACGCCAGGGCCGCCACACCGCGCGAGCGGTTCGAAGCCTCCATGCTCGCCTTCGTCGTCACCAACCGGCGCGACGACGGCGCCGACTCGCCCCGCCAGTTCGACCGCATGCGCGAGGCCGCCGAGACCGGCGAGGTGCCCGAGGACCGCGTCCTGGACGCCTGCTCACAGGCCGTCGTCTGGTACCTCAAGCGCAAGGAGCTGCCGGAGGCGGAGTACGAGTGGTTCCACGCCACCGGTGCCCGGCTGGCCGAGACACACGACCGGCTCGACCCCGGAGCGATCTCCTCCTGGTACCGCGCCCTCGCCATGGTCCCGGCCGCCGTCGGCGAGGCGGAGACCACCCGCCGCTACATGGAGTACGCGCGGGAGGCCGCCGAGGACACCATGGCGCGCCGCCCCCGCGCCTACGAGACGCACTTCCTGAAGACGTACCACGAGTCCTCGCTCAAGGAGCACATGTACCTCACGCGCGACCTCGACCGGGCCGAGGAGGCGGGGCGGGCCTTGATCGCCCTCGACCCGGCCTGGGCCCCCAGCTACGGCGAACTCGCCGAGGCCTACGCCGCCTTCGGCCGACCCGAGCAGGCAGCCGAGCTGTACGAGCAGGCGGTCGCGGCCGGTCCGCCGTACGTCGGCCACCACATGCTGCGTGCGGCAGGCTGCCACCGGAAGGCCGGCGCCGCCGACCGCGCCCTCGCCCTCCACCGGGACCTGGCCCGCCTCGCCCCCGACGACGAGCAGGTACTGCGCGACGGCCTCGACCTGGCCGACGGCTTGGGCGACGACACCTCCCGCCACCAGTTCCAGGCCGCGCTGGAGCGGCTGGGCCACGACGGCACCCGCGGCGCCGGCCCACAGGCGGGGGACCGGTAG	MSGATPDRIAFETVEVQANTFQETLLGLEYTTGPGRPADLFSRACVEQYADLRLDRFGYLLAQVFEPNVLHEAALLAGLSYDSLADLSHRPTEPVERLAALVRDAADLPVTALVNTAAALISVSRFDPAERLLADAYARAATPRERFEASMLAFVVTNRRDDGADSPRQFDRMREAAETGEVPEDRVLDACSQAVVWYLKRKELPEAEYEWFHATGARLAETHDRLDPGAISSWYRALAMVPAAVGEAETTRRYMEYAREAAEDTMARRPRAYETHFLKTYHESSLKEHMYLTRDLDRAEEAGRALIALDPAWAPSYGELAEAYAAFGRPEQAAELYEQAVAAGPPYVGHHMLRAAGCHRKAGAADRALALHRDLARLAPDDEQVLRDGLDLADGLGDDTSRHQFQAALERLGHDGTRGAGPQAGDR	MKNKGIDQFRVIAAMMVVAIHCLPLHYLWPEGDILITLTIFRVAVPFFFMISGYYVFAELAVANSYPSRQRVFNFIKKQLKVYLLATLMFLPLALYSQTIGFDLPVGTLVQVLLVNGILYHLWYFPALITGSLLLTSLLIHVSFKKVFWLAAGLYLIGLGGDSWFGLIQQTPIEPFYTAVFHLLDGTRNGIFFTPLFLCLGVLVRKQSEKRSLSKTALFFLISLIGLLIESAYLHGFSIPKHDSMYLFLPVVLFFLFPLILRWHPHRTWKHPGQLSLWLYLLHPYTIAGTHFLSQKISILQNNLINYLVVLILTIGFICLFLRQKHSWFRHKQTTPVKRAVKEFSKTALLHNLQEIQRIISPKTKVMAVVKADAYGCGAKEVAPVLEQAGIDFFAVATIDEGIRLRKNAVKSPILVLGYTSPKRIKELRRYSLTQSIISEGHAVALSQRKVAIDCHLAIDTGMHRLGVTPTIDSILSIFDLPFLTISGVYSHLGSADRLNPDSMIRTQKQIACFDQILLELDQRQISYGITHLQSSYGILNYPDLNYDYVRPGILLTGSLSDTNEPTKQRVSLQPILTLKAQLITKRVVAKGEAIGYGQTAVANQETTVGVVSIGYCDGLPRSLSNQEFCLSYRGQSLPQIGLICMDMLLIDLSHCPTIPIESEIEILTDWSDTAEQVQTITNELICRIGPRVSARIK	61.17	gnl|BL_ORD_ID|692|hsp_num:0	734		
BGC0000723.1|Validamycin_33 # 35999 # 36970 # -1 # ID=1_33;partial=00;start_type=GTG;rbs_motif=AAGG;rbs_spacer=12bp;gc_cont=0.705	BGC0000723.1|Validamycin_33 	35999	36970	-	Loose	550	26.9498	OXA-306	25.21	3001761	protein homolog model	n/a	n/a	cephalosporin; penam	antibiotic inactivation	OXA beta-lactamase	GTGCCAAGACTGCGGACGAAAACCGCGTTCGCCGGGCTGAGAACGGTCGCGCCCGACGCAGTGCCGCTGGACGCTGCCGCGGCGGTCGTCGGTTCCGGCTATTCCCTCGGCAGCGCCCACCAAGGGGCCGAAAACGGCCCCTTCTTTCTCCGGACGCTTTCCCAAGCGCATACCTGGGGTGCGGAACAGCCCGGAATCGTCCAACTGCGCAACGGGCGCGTCCCCCTGGAACGCGCGGTCGACATCGGCGACGTGCTCTTCGACGGCATGACGCTCGCCGACGCCCAGGAGGCACTCGCCCAGGTGATCGCCGCGCTGCCCGCCGGCACCGTCCCCGCGGTGATCGGCGGCGATCATACGGTCACCCTGCCGGTCGTCCAGGCGCTGTGGAAGCGGCGCCGGCGCCCCTTCACGGTCGTCCAGTTCGACCACCACCTGGACCTCCAGATCTGGGACGGCGCACCGACCCGGGACGTCCCCCGGGACCCGGTCTTCAACACCAACGTGATGTCCCACGTGTCCGACCTGGTCGGACCCGAGCGTCTCTTCCAGGTCGGGGTGGCGCCGTACGCCACGGTGGAGGCCGACAGCGCCGACGGCCTGGACGGCTACCTCCACGGCGTCGGACTGCAACTGCCGCTGCTGGCCCCGGAACTCGACGACCTCGAAGCCTTCCGGGCCGCCCTCGGCACCGGCACCGACGTCTACCTCACCGTCGACATCGACGTCCTGGACCGTTCGGTGATGTCCTCCACCGGCTATCCGGCGGAGGCCGGCCTGGGCACCCGGGACCTGTTGCGCCTCATCGACTGGGTGCTCCGGGACAACCGGCTCGTCGGCTTCGACCTGGTGGAGTTCGCCGCCCCCGCCGACGCCCGCGACGCCACCACGCTCTCGGATGCCGGCCGCGCCGTACTGGTGTTCCTGCATCTTCTCAACTGGGCGTGCCGCCAAGCGGCAGAGAGGGCGTGA	MPRLRTKTAFAGLRTVAPDAVPLDAAAAVVGSGYSLGSAHQGAENGPFFLRTLSQAHTWGAEQPGIVQLRNGRVPLERAVDIGDVLFDGMTLADAQEALAQVIAALPAGTVPAVIGGDHTVTLPVVQALWKRRRRPFTVVQFDHHLDLQIWDGAPTRDVPRDPVFNTNVMSHVSDLVGPERLFQVGVAPYATVEADSADGLDGYLHGVGLQLPLLAPELDDLEAFRAALGTGTDVYLTVDIDVLDRSVMSSTGYPAEAGLGTRDLLRLIDWVLRDNRLVGFDLVEFAAPADARDATTLSDAGRAVLVFLHLLNWACRQAAERA	MSKRLKTLALSASFTFALPLVACQSFGDQTQHIMAQKSEQQNIATLFQQAQTSGVLVIYDGKKIQKYGNDTSRAEQRYIPASTFKMLNALIGIQHHKTTPNEVFKWDGQKRAFSSWEKDLTLAEAMQASAVPVYQELARRIGLELMTREVKRVGYGNKNIGTQVDNFWLVGPLKITPVEEVRFAYALAKQKLPFDQSTQQQVKGMLLIDEVQGTKIYAKSGWGMDVNPQVGWWTGWIEQANGKVTAFSLNMEMNRPEHADARKAIVYQALQQLDLLAN	116.19	gnl|BL_ORD_ID|2612|hsp_num:0	3468		
